data_1gh1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gh1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.549 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' GLY . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.453 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 122.944 1.354 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.569 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 69' ' ' ILE . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.593 HG23 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 47' ' ' ALA . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.496 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.533 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB1' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.49 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.881 0.372 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.437 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.59 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.46 ' NH2' ' OE1' ' A' ' 45' ' ' GLN . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.539 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE2' ' SG ' ' A' ' 48' ' ' CYS . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD23 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.173 0.511 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.621 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.536 ' CA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.439 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.532 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HD3' ' NE2' ' A' ' 35' ' ' HIS . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.503 0.192 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 6' ' ' VAL . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.56 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.62 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.407 ' CG2' HD23 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.525 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.554 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.63 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' CG2' ' A' ' 17' ' ' VAL . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' VAL . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG23 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG23 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.4 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 HG12 ' CD2' ' A' ' 14' ' ' LEU . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.461 ' CD2' HD13 ' A' ' 9' ' ' LEU . 49.2 t60 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 5' ' ' HIS . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.555 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.57 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 2.0 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' CD ' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.403 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.718 0.294 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.439 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' C ' ' NE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 79' ' ' TYR . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG13 ' SG ' ' A' ' 50' ' ' CYS . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG22 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' CD1' HG22 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' CG2' HD12 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' HG21 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.672 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.672 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.624 ' SG ' HG13 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 82.6 m-20 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.515 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 122.271 1.034 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.561 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.595 ' SG ' HG22 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.595 HG22 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 48' ' ' CYS . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' N ' HD11 ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.451 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' A' ' 81' ' ' ILE . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.482 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.571 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG23 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 13' ' ' CYS . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG23 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB3' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' SG ' ' A' ' 27' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.489 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' N ' HD11 ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 123.058 1.409 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG11 ' CD1' ' A' ' 34' ' ' LEU . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG23 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.449 HD12 ' SG ' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.299 1.2 m-20 -97.83 46.72 1.01 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.749 1.261 . . . . 0.0 110.185 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t 50.92 63.68 2.14 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.549 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.626 ' SG ' HG22 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 30' ' ' GLY . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 26' ' ' GLN . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG22 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.453 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -162.31 169.73 20.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.5 mt -113.9 51.09 0.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.92 25.4 9.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.662 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.12 165.82 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.611 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -38.2 5.44 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.969 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.401 ' HA ' ' CG2' ' A' ' 90' ' ' VAL . 51.5 m 62.02 19.07 10.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 125.531 1.77 . . . . 0.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p -86.75 -47.04 9.45 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.554 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 44.52 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.396 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.6 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.129 -1.415 . . . . 0.0 109.058 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.298 1.2 m-20 -98.33 54.11 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 123.544 1.64 . . . . 0.0 110.439 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t 47.5 36.33 5.07 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.909 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.569 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.575 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' HG23 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 69' ' ' ILE . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.405 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.593 HG23 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.475 HH21 ' C ' ' A' ' 90' ' ' VAL . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' HB1' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 47' ' ' ALA . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.496 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.478 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.533 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.461 ' OH ' ' HB1' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.49 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t -154.77 -168.48 2.91 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -138.68 43.24 2.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 123.993 0.808 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.92 -33.55 6.26 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.594 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 85' ' ' ILE . 4.4 mp -67.91 157.96 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 123.89 0.744 . . . . 0.0 110.154 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.91 -40.51 12.34 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 82.4 m 56.6 21.5 5.82 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -95.56 -42.57 8.36 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -135.9 53.46 1.95 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.213 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.475 ' C ' HH21 ' A' ' 44' ' ' ARG . 31.7 m . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 123.386 1.565 . . . . 0.0 107.531 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.4 138.98 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.846 0.831 . . . . 0.0 109.141 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t -67.04 -17.32 64.85 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.569 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 HD11 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG22 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' NH2' ' HB3' ' A' ' 88' ' ' SER . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.543 HE21 ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.427 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.453 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.539 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.539 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE2' ' SG ' ' A' ' 48' ' ' CYS . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD11 HD23 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.29 30.69 4.17 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.3 mt 36.68 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.66 22.53 11.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 123.646 0.591 . . . . 0.0 110.29 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.479 HG23 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -149.31 156.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 123.318 0.386 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 90' ' ' VAL . 4.4 t70 -123.59 -20.08 5.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 124.401 1.063 . . . . 0.0 111.863 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 96.1 m 68.87 -55.46 0.54 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.514 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.1 t 175.31 -51.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.543 ' N ' HE21 ' A' ' 45' ' ' GLN . 15.5 ttm-85 -161.87 40.92 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 86' ' ' ASP . 11.5 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 115.825 -2.036 . . . . 0.0 106.588 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -88.25 132.07 34.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.333 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t -61.76 -19.67 62.72 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.412 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.557 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.621 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.536 ' CA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.439 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.532 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.406 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 68' ' ' SER . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HD3' ' NE2' ' A' ' 35' ' ' HIS . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -146.95 177.46 9.11 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.25 44.15 1.88 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.927 0.87 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.18 -28.35 8.31 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.002 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 85' ' ' ILE . 3.9 mp -89.33 163.26 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.817 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.41 -24.62 13.04 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.432 1.082 . . . . 0.0 113.611 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 62.7 m 55.32 16.8 1.84 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.86 0.725 . . . . 0.0 112.366 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -99.72 -32.09 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.602 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -105.8 -44.32 4.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.159 0.912 . . . . 0.0 111.88 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 114.568 -2.634 . . . . 0.0 109.744 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.92 143.94 44.74 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.143 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.24 -18.95 52.37 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.431 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 6' ' ' VAL . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.56 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.62 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 HD23 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.62 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.403 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.429 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.407 ' CG2' HD23 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 39.1 t -159.61 179.87 8.5 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.49 ' N ' ' OG ' ' A' ' 82' ' ' SER . 31.0 mt -118.95 30.06 7.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.95 33.76 5.48 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -144.42 152.18 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.32 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.04 101.41 7.4 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.527 1.142 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.414 ' SG ' ' CG ' ' A' ' 79' ' ' TYR . 68.6 m -59.21 -52.57 65.13 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t 169.45 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.61 41.09 0.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.413 HG23 ' CB ' ' A' ' 46' ' ' SER . 16.6 tt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.0 41.6 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.221 0.534 . . . . 0.0 111.033 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t 49.42 36.18 9.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.525 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.554 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.63 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.63 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.413 ' CB ' HG23 ' A' ' 1' ' ' ILE . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.48 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' CG2' ' A' ' 17' ' ' VAL . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.465 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.458 ' HB3' HG22 ' A' ' 85' ' ' ILE . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.58 167.16 31.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.52 35.61 4.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.19 -10.27 13.4 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 124.103 0.877 . . . . 0.0 111.344 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.458 HG22 ' HB3' ' A' ' 79' ' ' TYR . 3.6 mp -84.14 150.34 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.96 -37.43 12.86 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.902 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m 51.86 23.97 2.33 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.274 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 t -105.17 -23.36 12.92 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -137.21 34.64 2.55 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 115.938 -1.982 . . . . 0.0 108.627 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.39 142.97 51.02 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t -76.54 67.59 2.72 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.59 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 6' ' ' VAL . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.428 ' SG ' HG23 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG23 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 87' ' ' CYS . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.602 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.431 ' ND2' HG23 ' A' ' 90' ' ' VAL . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HB3' HG13 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.4 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.437 HG12 ' CD2' ' A' ' 14' ' ' LEU . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m -163.22 -171.45 2.62 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -131.8 31.31 4.24 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.014 0.821 . . . . 0.0 110.728 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -128.02 29.74 5.36 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.691 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 85.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.368 0.604 . . . . 0.0 110.379 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.38 86.96 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.199 -1.0 . . . . 0.0 113.576 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' NH1' ' A' ' 44' ' ' ARG . 51.9 m -47.67 -58.67 4.0 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.362 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.405 ' CB ' HH12 ' A' ' 44' ' ' ARG . 5.0 m 175.07 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.801 1.313 . . . . 0.0 110.461 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -157.72 35.35 0.26 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.592 HG11 ' SG ' ' A' ' 48' ' ' CYS . 2.3 p . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 112.334 -3.698 . . . . 0.0 108.431 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 55.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 118.923 -0.56 . . . . 0.0 109.543 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -170.85 37.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.461 ' CD2' HD13 ' A' ' 9' ' ' LEU . 49.2 t60 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.504 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD13 ' CD2' ' A' ' 5' ' ' HIS . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.555 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.548 ' SG ' HG23 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.57 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.564 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 2.0 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.437 ' CD ' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 HG23 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' CD1' ' A' ' 85' ' ' ILE . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.504 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.47 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.437 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.465 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.46 ' C ' HD12 ' A' ' 83' ' ' LEU . 41.6 t -155.17 -168.91 3.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 82' ' ' SER . 6.5 mp -128.44 43.65 3.1 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.346 0.593 . . . . 0.0 109.842 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -97.08 -55.39 2.87 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.199 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -77.91 151.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.46 28.78 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 117.307 -1.757 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 38.1 m 47.15 11.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 p -119.51 30.69 6.95 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.049 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 40.45 0.56 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' CG1' ' HB2' ' A' ' 78' ' ' PRO . 35.8 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 114.187 -2.816 . . . . 0.0 112.622 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -105.52 138.46 41.67 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t -61.29 -20.06 62.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.47 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.439 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG13 ' CD1' ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' HG23 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.428 ' NE2' ' H ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' A' ' 90' ' ' VAL . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' C ' ' NE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.434 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.477 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.658 ' CD2' ' SG ' ' A' ' 87' ' ' CYS . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -164.37 151.48 11.58 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.95 54.46 0.85 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -133.31 31.98 3.73 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.592 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -146.95 155.34 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.375 -0.828 . . . . 0.0 111.439 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.31 96.16 3.81 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.658 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 33.2 m -55.75 -60.87 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.155 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -178.63 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.428 ' H ' ' NE2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -156.96 40.37 0.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' A' ' 48' ' ' CYS . 2.8 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 111.785 -3.96 . . . . 0.0 108.311 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.425 ' H2 ' ' CD1' ' A' ' 1' ' ' ILE . 2.0 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.3 m-20 -97.69 45.94 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.311 1.053 . . . . 0.0 109.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.95 56.58 7.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG13 ' SG ' ' A' ' 50' ' ' CYS . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG22 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' CD1' HG22 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' CG2' HD12 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.618 ' SG ' HG21 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG22 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.672 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.672 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.624 ' SG ' HG13 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.48 ' HZ3' ' C ' ' A' ' 90' ' ' VAL . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.411 HG22 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 82.6 m-20 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.618 HG21 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t 46.03 -148.66 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.442 ' H ' HD13 ' A' ' 83' ' ' LEU . 3.2 mp -89.96 31.82 0.95 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.758 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -93.33 0.87 57.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.88 152.77 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.403 -0.811 . . . . 0.0 109.785 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.57 100.79 8.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -60.86 -51.62 68.52 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.627 0.727 . . . . 0.0 112.579 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 t 173.72 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.514 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.618 ' N ' HE21 ' A' ' 45' ' ' GLN . 2.8 ttm180 -165.0 43.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' C ' ' HZ3' ' A' ' 52' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 122.254 1.026 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.37 148.74 44.37 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t -75.84 68.19 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.714 ' HD2' ' SG ' ' A' ' 87' ' ' CYS . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.505 HD11 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 18.2 t -175.52 -168.01 0.28 Allowed 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.484 ' N ' ' OG ' ' A' ' 82' ' ' SER . 4.1 mp -137.39 45.69 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 123.789 0.681 . . . . 0.0 110.323 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.52 5.56 34.07 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.228 0.537 . . . . 0.0 111.037 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.85 148.76 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.539 -0.725 . . . . 0.0 111.477 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -86.18 -15.32 41.34 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.675 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.714 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 45.0 m 52.15 17.97 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 p -104.33 -43.92 5.08 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.979 0.895 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.61 32.0 5.37 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.995 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.499 2.019 0 O-C-N 125.646 1.841 . . . . 0.0 109.824 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.7 tt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.51 145.13 29.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t -76.69 67.79 2.84 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.242 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.561 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.595 ' SG ' HG22 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.595 HG22 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.569 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.476 HD11 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.441 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 48' ' ' CYS . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 ' N ' HD11 ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t -150.36 -173.16 4.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.3 44.3 2.0 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.003 0.814 . . . . 0.0 111.23 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -136.71 30.81 2.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.995 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -147.22 176.85 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.21 119.3 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.735 1.272 . . . . 0.0 107.986 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' HB3' ' HE ' ' A' ' 44' ' ' ARG . 92.0 m -67.15 -42.28 84.64 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.259 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t 165.54 -51.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 123.865 0.728 . . . . 0.0 109.59 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -161.28 41.78 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 114.131 -2.842 . . . . 0.0 107.431 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.24 -79.53 0.58 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t -171.92 40.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.451 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.416 ' O ' HD12 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.55 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' A' ' 81' ' ' ILE . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' ' NH2' ' A' ' 89' ' ' ARG . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.543 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.482 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' HG23 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.404 ' HA ' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t -152.57 164.6 37.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -106.12 54.91 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -121.8 -55.17 1.91 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.992 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -60.2 161.3 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.672 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -121.9 89.21 3.08 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.489 0.662 . . . . 0.0 111.748 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.4 m -61.73 -8.04 4.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.28 -0.888 . . . . 0.0 112.944 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -83.21 -7.7 59.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 109.341 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -138.44 44.7 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.504 2.231 0 CA-C-O 117.02 -1.467 . . . . 0.0 110.735 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.4 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -170.09 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.571 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG23 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 13' ' ' CYS . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG23 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HA ' HG13 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HB3' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' SG ' ' A' ' 27' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.489 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' N ' HD11 ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -154.8 172.8 17.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.91 44.72 2.12 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.574 -0.451 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -115.2 -27.32 7.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.294 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.26 160.53 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.75 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -92.18 -36.91 13.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.2 m 75.77 -56.02 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.636 0.731 . . . . 0.0 110.324 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.9 t -75.68 -29.44 59.05 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.958 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.468 ' C ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -119.73 61.08 0.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.604 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.448 ' C ' HH21 ' A' ' 89' ' ' ARG . 30.2 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.03 141.03 58.31 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.753 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t -80.47 67.74 6.42 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.452 -1.699 . . . . 0.0 110.442 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG11 ' CD1' ' A' ' 34' ' ' LEU . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' HD12 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG23 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' CD1' HG11 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 85' ' ' ILE . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.536 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.449 HD12 ' SG ' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t -163.2 -176.37 4.78 Favored 'General case' 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.97 29.36 6.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.417 1.073 . . . . 0.0 109.029 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -91.11 -61.67 1.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.553 0.533 . . . . 0.0 111.447 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.505 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -76.7 158.31 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 27.95 8.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.591 0.557 . . . . 0.0 110.571 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.3 m 52.52 14.84 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 p -110.9 -52.24 2.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.032 0.833 . . . . 0.0 111.6 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -103.4 52.14 0.78 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.524 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 117.564 -1.207 . . . . 0.0 109.36 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 54' ' ' ILE . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 24' ' ' SER . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 14' ' ' LEU . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 13' ' ' CYS . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 14' ' ' LEU . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 122.944 1.354 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.55 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.62 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 54' ' ' ILE . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.616 HG21 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' HD1' ' C ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.55 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 14' ' ' LEU . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.881 0.372 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 47' ' ' ALA . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 51' ' ' LEU . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.46 ' NH2' ' OE1' ' A' ' 45' ' ' GLN . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.412 HG12 HH11 ' A' ' 11' ' ' ARG . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE2' ' SG ' ' A' ' 48' ' ' CYS . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.173 0.511 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 11' ' ' ARG . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.594 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' ILE . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 23' ' ' PRO . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.462 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 44' ' ' ARG . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 14' ' ' LEU . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 13' ' ' CYS . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.503 0.192 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 51' ' ' LEU . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.48 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.423 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' HD21 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.556 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.556 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 34' ' ' LEU . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.697 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 13' ' ' CYS . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.576 ' HB ' HD21 ' A' ' 51' ' ' LEU . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 65' ' ' ASN . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 66' ' ' ALA . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.628 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.576 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' LEU . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 81' ' ' ILE . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ILE . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 17' ' ' VAL . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 47' ' ' ALA . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 54' ' ' ILE . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.448 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 15' ' ' SER . 12.3 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.492 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 14' ' ' LEU . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HE2' ' HD3' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.718 0.294 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.439 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 47' ' ' ALA . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.567 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 66' ' ' ALA . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 ' HB1' ' A' ' 47' ' ' ALA . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.717 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' C ' ' NE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' ILE . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.441 HG22 HD21 ' A' ' 61' ' ' LEU . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.469 ' ND1' HD11 ' A' ' 9' ' ' LEU . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 47' ' ' ALA . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.469 HD11 ' ND1' ' A' ' 5' ' ' HIS . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.611 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.491 ' CZ ' ' ND2' ' A' ' 65' ' ' ASN . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.599 ' CG2' HD11 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG21 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.721 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.721 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.613 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' HG11 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 80' ' ' THR . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 23.8 m120 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 80' ' ' THR . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.64 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 34' ' ' LEU . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.611 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.666 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.666 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 122.271 1.034 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 51' ' ' LEU . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 66' ' ' ALA . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG21 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.533 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD12 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.43 ' C ' ' HD1' ' A' ' 59' ' ' HIS . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.554 ' CE2' HD12 ' A' ' 51' ' ' LEU . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.491 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' VAL . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' ALA . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' SER . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 69' ' ' ILE . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.529 HD11 HG13 ' A' ' 6' ' ' VAL . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 81' ' ' ILE . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 81' ' ' ILE . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG11 ' HA ' ' A' ' 47' ' ' ALA . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 54' ' ' ILE . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HG2' ' H ' ' A' ' 24' ' ' SER . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.425 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 34' ' ' LEU . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 14' ' ' LEU . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 13' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 123.058 1.409 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 47' ' ' ALA . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.511 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 16.0 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG21 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' CD1' HG13 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.299 1.2 m-20 -97.83 46.72 1.01 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.749 1.261 . . . . 0.0 110.185 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t 50.92 63.68 2.14 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 54' ' ' ILE . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 24' ' ' SER . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 14' ' ' LEU . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 13' ' ' CYS . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 14' ' ' LEU . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -162.31 169.73 20.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.5 mt -113.9 51.09 0.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.92 25.4 9.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.662 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.12 165.82 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.611 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -38.2 5.44 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.969 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.44 ' HA ' ' CG2' ' A' ' 90' ' ' VAL . 51.5 m 62.02 19.07 10.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 125.531 1.77 . . . . 0.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p -86.75 -47.04 9.45 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.554 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 44.52 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.396 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.6 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.129 -1.415 . . . . 0.0 109.058 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.298 1.2 m-20 -98.33 54.11 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 123.544 1.64 . . . . 0.0 110.439 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t 47.5 36.33 5.07 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.909 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.55 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.62 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 54' ' ' ILE . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.616 HG21 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' HD1' ' C ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.445 HH21 ' C ' ' A' ' 90' ' ' VAL . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.55 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 14' ' ' LEU . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t -154.77 -168.48 2.91 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -138.68 43.24 2.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 123.993 0.808 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.92 -33.55 6.26 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.594 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.626 ' H ' HD12 ' A' ' 85' ' ' ILE . 4.4 mp -67.91 157.96 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 123.89 0.744 . . . . 0.0 110.154 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.91 -40.51 12.34 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 82.4 m 56.6 21.5 5.82 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -95.56 -42.57 8.36 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -135.9 53.46 1.95 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.213 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.445 ' C ' HH21 ' A' ' 44' ' ' ARG . 31.7 m . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 123.386 1.565 . . . . 0.0 107.531 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.4 138.98 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.846 0.831 . . . . 0.0 109.141 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t -67.04 -17.32 64.85 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 47' ' ' ALA . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 51' ' ' LEU . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.407 ' O ' ' NE2' ' A' ' 45' ' ' GLN . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.688 HH21 ' NE2' ' A' ' 45' ' ' GLN . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.688 ' NE2' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.412 HG12 HH11 ' A' ' 11' ' ' ARG . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HA ' HG21 ' A' ' 85' ' ' ILE . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.29 30.69 4.17 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.3 mt 36.68 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.66 22.53 11.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 123.646 0.591 . . . . 0.0 110.29 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG21 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -149.31 156.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 123.318 0.386 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' VAL . 4.4 t70 -123.59 -20.08 5.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 124.401 1.063 . . . . 0.0 111.863 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 96.1 m 68.87 -55.46 0.54 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.585 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.1 t 175.31 -51.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -161.87 40.92 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 86' ' ' ASP . 11.5 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 115.825 -2.036 . . . . 0.0 106.588 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -88.25 132.07 34.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.333 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t -61.76 -19.67 62.72 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.412 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 11' ' ' ARG . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.594 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' ILE . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 23' ' ' PRO . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.462 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 44' ' ' ARG . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 14' ' ' LEU . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 13' ' ' CYS . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -146.95 177.46 9.11 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.25 44.15 1.88 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.927 0.87 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.18 -28.35 8.31 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.002 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 85' ' ' ILE . 3.9 mp -89.33 163.26 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.817 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.41 -24.62 13.04 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.432 1.082 . . . . 0.0 113.611 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 62.7 m 55.32 16.8 1.84 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.86 0.725 . . . . 0.0 112.366 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -99.72 -32.09 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.602 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -105.8 -44.32 4.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.159 0.912 . . . . 0.0 111.88 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 114.568 -2.634 . . . . 0.0 109.744 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.92 143.94 44.74 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.143 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.24 -18.95 52.37 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.431 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 51' ' ' LEU . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.48 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 90' ' ' VAL . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' HD21 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.556 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.556 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' HA ' HG13 ' A' ' 85' ' ' ILE . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 39.1 t -159.61 179.87 8.5 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.49 ' N ' ' OG ' ' A' ' 82' ' ' SER . 31.0 mt -118.95 30.06 7.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.95 33.76 5.48 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -144.42 152.18 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.32 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.04 101.41 7.4 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.527 1.142 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.414 ' SG ' ' CG ' ' A' ' 79' ' ' TYR . 68.6 m -59.21 -52.57 65.13 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t 169.45 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.61 41.09 0.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 48' ' ' CYS . 7.2 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.44 HG23 ' CB ' ' A' ' 46' ' ' SER . 16.6 tt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.0 41.6 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.221 0.534 . . . . 0.0 111.033 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t 49.42 36.18 9.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD23 ' C ' ' A' ' 34' ' ' LEU . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 1' ' ' ILE . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.697 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 13' ' ' CYS . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 85' ' ' ILE . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.58 167.16 31.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.52 35.61 4.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.19 -10.27 13.4 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 124.103 0.877 . . . . 0.0 111.344 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 79' ' ' TYR . 3.6 mp -84.14 150.34 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.96 -37.43 12.86 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.902 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m 51.86 23.97 2.33 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.274 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 t -105.17 -23.36 12.92 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -137.21 34.64 2.55 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 115.938 -1.982 . . . . 0.0 108.627 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.39 142.97 51.02 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t -76.54 67.59 2.72 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.576 ' HB ' HD21 ' A' ' 51' ' ' LEU . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 65' ' ' ASN . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 66' ' ' ALA . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 87' ' ' CYS . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.628 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' ND2' HG23 ' A' ' 90' ' ' VAL . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' LEU . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 81' ' ' ILE . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ILE . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 17' ' ' VAL . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m -163.22 -171.45 2.62 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -131.8 31.31 4.24 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.014 0.821 . . . . 0.0 110.728 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -128.02 29.74 5.36 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.691 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -132.3 85.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.368 0.604 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.38 86.96 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.199 -1.0 . . . . 0.0 113.576 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' NH1' ' A' ' 44' ' ' ARG . 51.9 m -47.67 -58.67 4.0 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.362 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.427 ' CB ' HH12 ' A' ' 44' ' ' ARG . 5.0 m 175.07 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.801 1.313 . . . . 0.0 110.461 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -157.72 35.35 0.26 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG11 ' SG ' ' A' ' 48' ' ' CYS . 2.3 p . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 112.334 -3.698 . . . . 0.0 108.431 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 55.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 118.923 -0.56 . . . . 0.0 109.543 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -170.85 37.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 47' ' ' ALA . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 54' ' ' ILE . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.448 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.448 ' OE1' ' HA ' ' A' ' 15' ' ' SER . 12.3 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' CD1' ' A' ' 85' ' ' ILE . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.492 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 14' ' ' LEU . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HE2' ' HD3' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.487 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CB ' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.571 ' N ' HD12 ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.483 ' C ' HD12 ' A' ' 83' ' ' LEU . 41.6 t -155.17 -168.91 3.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 82' ' ' SER . 6.5 mp -128.44 43.65 3.1 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.346 0.593 . . . . 0.0 109.842 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -97.08 -55.39 2.87 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.199 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -77.91 151.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.46 28.78 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 117.307 -1.757 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 38.1 m 47.15 11.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 p -119.51 30.69 6.95 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.049 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 40.45 0.56 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 78' ' ' PRO . 35.8 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 114.187 -2.816 . . . . 0.0 112.622 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -105.52 138.46 41.67 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t -61.29 -20.06 62.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.47 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.439 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 47' ' ' ALA . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.567 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 66' ' ' ALA . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 ' HB1' ' A' ' 47' ' ' ALA . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 87' ' ' CYS . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 90' ' ' VAL . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.717 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' C ' ' NE ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' ILE . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.658 ' CD2' ' SG ' ' A' ' 87' ' ' CYS . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.441 HG22 HD21 ' A' ' 61' ' ' LEU . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -164.37 151.48 11.58 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.95 54.46 0.85 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -133.31 31.98 3.73 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.592 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -146.95 155.34 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.375 -0.828 . . . . 0.0 111.439 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.31 96.16 3.81 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.658 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 33.2 m -55.75 -60.87 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.155 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -178.63 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -156.96 40.37 0.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 48' ' ' CYS . 2.8 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 111.785 -3.96 . . . . 0.0 108.311 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.3 m-20 -97.69 45.94 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.311 1.053 . . . . 0.0 109.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.95 56.58 7.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.469 ' ND1' HD11 ' A' ' 9' ' ' LEU . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 47' ' ' ALA . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.469 HD11 ' ND1' ' A' ' 5' ' ' HIS . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.611 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.491 ' CZ ' ' ND2' ' A' ' 65' ' ' ASN . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.599 ' CG2' HD11 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG21 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD23 ' C ' ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.721 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.721 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.613 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' HG11 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 80' ' ' THR . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' NZ ' ' OXT' ' A' ' 90' ' ' VAL . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 23.8 m120 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 80' ' ' THR . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t 46.03 -148.66 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.2 mp -89.96 31.82 0.95 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.758 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -93.33 0.87 57.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.88 152.77 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.403 -0.811 . . . . 0.0 109.785 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.57 100.79 8.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -60.86 -51.62 68.52 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.627 0.727 . . . . 0.0 112.579 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 t 173.72 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.514 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.699 ' N ' HE21 ' A' ' 45' ' ' GLN . 2.8 ttm180 -165.0 43.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' OXT' ' NZ ' ' A' ' 52' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 122.254 1.026 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.37 148.74 44.37 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t -75.84 68.19 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.64 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 34' ' ' LEU . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.611 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.666 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HD2' ' SG ' ' A' ' 87' ' ' CYS . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.666 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 18.2 t -175.52 -168.01 0.28 Allowed 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.484 ' N ' ' OG ' ' A' ' 82' ' ' SER . 4.1 mp -137.39 45.69 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 123.789 0.681 . . . . 0.0 110.323 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.52 5.56 34.07 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.228 0.537 . . . . 0.0 111.037 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.85 148.76 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.539 -0.725 . . . . 0.0 111.477 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -86.18 -15.32 41.34 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.675 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.753 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 45.0 m 52.15 17.97 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 p -104.33 -43.92 5.08 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.979 0.895 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.61 32.0 5.37 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.995 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.499 2.019 0 O-C-N 125.646 1.841 . . . . 0.0 109.824 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.7 tt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.51 145.13 29.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t -76.69 67.79 2.84 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.242 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 51' ' ' LEU . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 66' ' ' ALA . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG21 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HE ' ' HB3' ' A' ' 87' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.533 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD12 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.43 ' C ' ' HD1' ' A' ' 59' ' ' HIS . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.554 ' CE2' HD12 ' A' ' 51' ' ' LEU . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.491 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t -150.36 -173.16 4.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.3 44.3 2.0 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.003 0.814 . . . . 0.0 111.23 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -136.71 30.81 2.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.995 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -147.22 176.85 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.21 119.3 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.735 1.272 . . . . 0.0 107.986 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.424 ' HB3' ' HE ' ' A' ' 44' ' ' ARG . 92.0 m -67.15 -42.28 84.64 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.259 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 44' ' ' ARG . 8.5 t 165.54 -51.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 123.865 0.728 . . . . 0.0 109.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -161.28 41.78 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 114.131 -2.842 . . . . 0.0 107.431 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.24 -79.53 0.58 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t -171.92 40.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' VAL . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' ALA . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' SER . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 69' ' ' ILE . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.529 HD11 HG13 ' A' ' 6' ' ' VAL . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' ' NH2' ' A' ' 89' ' ' ARG . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 81' ' ' ILE . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 81' ' ' ILE . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HA ' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t -152.57 164.6 37.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -106.12 54.91 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -121.8 -55.17 1.91 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.992 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -60.2 161.3 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.672 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -121.9 89.21 3.08 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.489 0.662 . . . . 0.0 111.748 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.4 m -61.73 -8.04 4.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.28 -0.888 . . . . 0.0 112.944 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -83.21 -7.7 59.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 109.341 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -138.44 44.7 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.504 2.231 0 CA-C-O 117.02 -1.467 . . . . 0.0 110.735 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.4 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -170.09 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG11 ' HA ' ' A' ' 47' ' ' ALA . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 54' ' ' ILE . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HG2' ' H ' ' A' ' 24' ' ' SER . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.425 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 34' ' ' LEU . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 14' ' ' LEU . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 13' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -154.8 172.8 17.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.91 44.72 2.12 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.574 -0.451 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -115.2 -27.32 7.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.294 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.26 160.53 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.75 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' CYS . 8.9 t70 -92.18 -36.91 13.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 64.2 m 75.77 -56.02 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.636 0.731 . . . . 0.0 110.324 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.9 t -75.68 -29.44 59.05 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.958 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' C ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -119.73 61.08 0.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.604 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' C ' HH21 ' A' ' 89' ' ' ARG . 30.2 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.03 141.03 58.31 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.753 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t -80.47 67.74 6.42 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.452 -1.699 . . . . 0.0 110.442 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 47' ' ' ALA . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.511 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.511 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 16.0 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG21 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' CD1' HG13 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' HD13 ' A' ' 85' ' ' ILE . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t -163.2 -176.37 4.78 Favored 'General case' 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.97 29.36 6.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.417 1.073 . . . . 0.0 109.029 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -91.11 -61.67 1.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.553 0.533 . . . . 0.0 111.447 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.526 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -76.7 158.31 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 27.95 8.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.591 0.557 . . . . 0.0 110.571 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.3 m 52.52 14.84 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 p -110.9 -52.24 2.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.032 0.833 . . . . 0.0 111.6 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -103.4 52.14 0.78 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.524 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 117.564 -1.207 . . . . 0.0 109.36 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 54' ' ' ILE . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 24' ' ' SER . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 14' ' ' LEU . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 13' ' ' CYS . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 14' ' ' LEU . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 122.944 1.354 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.55 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.62 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 54' ' ' ILE . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.616 HG21 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.441 ' HD1' ' C ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.55 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 14' ' ' LEU . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.881 0.372 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 47' ' ' ALA . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 51' ' ' LEU . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.46 ' NH2' ' OE1' ' A' ' 45' ' ' GLN . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.46 ' OE1' ' NH2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.412 HG12 HH11 ' A' ' 11' ' ' ARG . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.571 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE2' ' SG ' ' A' ' 48' ' ' CYS . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.173 0.511 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 11' ' ' ARG . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.594 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' ILE . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 23' ' ' PRO . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.569 ' CA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.462 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 44' ' ' ARG . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 14' ' ' LEU . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 13' ' ' CYS . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.503 0.192 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 51' ' ' LEU . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.48 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.423 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' HD21 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.556 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.556 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 34' ' ' LEU . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.697 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 13' ' ' CYS . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.576 ' HB ' HD21 ' A' ' 51' ' ' LEU . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 65' ' ' ASN . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 66' ' ' ALA . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.628 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.576 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' LEU . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 81' ' ' ILE . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ILE . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 17' ' ' VAL . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.488 ' CD2' HD11 ' A' ' 9' ' ' LEU . 49.2 t60 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 47' ' ' ALA . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 5' ' ' HIS . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 54' ' ' ILE . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.594 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 2.0 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.492 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 14' ' ' LEU . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HE2' ' HD3' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' CD1' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.718 0.294 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 47' ' ' ALA . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.567 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.403 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 66' ' ' ALA . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 1.6 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 ' HB1' ' A' ' 47' ' ' ALA . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.717 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.448 ' NE ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' ILE . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE1' HD13 ' A' ' 51' ' ' LEU . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.441 HG22 HD21 ' A' ' 61' ' ' LEU . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t . . . . . 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.469 ' ND1' HD11 ' A' ' 9' ' ' LEU . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 47' ' ' ALA . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.469 HD11 ' ND1' ' A' ' 5' ' ' HIS . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.611 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.599 ' CG2' HD11 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG21 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.721 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.721 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.613 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' HG11 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 80' ' ' THR . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 82.6 m-20 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 80' ' ' THR . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.64 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 34' ' ' LEU . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.611 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.666 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.666 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 122.271 1.034 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 51' ' ' LEU . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 66' ' ' ALA . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.606 HG21 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' HG2' ' SG ' ' A' ' 48' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.533 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD12 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.43 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.554 ' CE2' HD12 ' A' ' 51' ' ' LEU . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.491 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t . . . . . 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' VAL . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' ALA . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' SER . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 69' ' ' ILE . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.529 HD11 HG13 ' A' ' 6' ' ' VAL . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 81' ' ' ILE . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.498 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 81' ' ' ILE . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.624 HG11 ' HA ' ' A' ' 47' ' ' ALA . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 54' ' ' ILE . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HG2' ' H ' ' A' ' 24' ' ' SER . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.425 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' C ' HD23 ' A' ' 34' ' ' LEU . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 14' ' ' LEU . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 13' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 123.058 1.409 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 47' ' ' ALA . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG21 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.568 ' CD1' HG13 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.0 mt . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.299 1.2 m-20 -97.83 46.72 1.01 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 122.749 1.261 . . . . 0.0 110.185 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.2 t 50.92 63.68 2.14 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.81 1.29 . . . . 0.0 111.658 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.44 -45.02 0.53 Allowed Glycine 0 N--CA 1.503 3.111 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -98.76 -31.73 11.74 Favored 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.663 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 47' ' ' ALA . 99.7 t -57.44 -34.73 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 121.359 0.6 . . . . 0.0 110.508 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' HB3' ' NH1' ' A' ' 11' ' ' ARG . 1.5 m-20 -54.52 -56.99 13.16 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.182 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -64.75 -21.24 66.72 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' A' ' 34' ' ' LEU . 20.2 mt -73.65 -46.59 45.7 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.762 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.26 -15.89 9.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.02 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.584 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -52.0 -47.4 91.49 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.317 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.4 Cg_endo -59.19 -25.18 77.2 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.625 1.55 . . . . 0.0 113.822 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.2 m -77.65 -22.55 50.49 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.774 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 54' ' ' ILE . 17.8 mt -63.2 -32.09 73.4 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.868 0.842 . . . . 0.0 111.248 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.8 m -53.88 -22.44 9.93 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.264 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -97.25 -43.93 7.13 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 25.7 t -53.44 -33.27 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.78 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.98 -24.01 67.7 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.774 -1.204 . . . . 0.0 112.402 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.06 38.95 2.38 Favored Glycine 0 N--CA 1.5 2.946 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.62 -170.16 12.02 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.68 132.89 24.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.383 1.389 . . . . 0.0 109.714 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.5 -160.72 33.01 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 24' ' ' SER . 83.9 Cg_endo -73.17 -61.39 0.05 OUTLIER 'Cis proline' 0 C--N 1.309 -1.546 0 C-N-CA 124.314 -1.119 . . . . 0.0 112.342 0.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 50.9 p 170.62 161.79 0.07 Allowed 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.156 0.91 . . . . 0.0 109.509 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.75 -5.11 56.12 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -94.24 -28.2 15.74 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.2 t -57.78 -44.64 86.38 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.4 m -76.14 -52.48 10.02 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.23 -0.988 . . . . 0.0 111.547 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -46.5 78.75 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.157 0.98 . . . . 0.0 109.133 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.54 -51.26 59.83 Favored Glycine 0 N--CA 1.491 2.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.936 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 13' ' ' CYS . 27.4 t -75.46 -37.52 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.843 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.63 -41.02 94.06 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -57.98 -59.01 5.93 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.609 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 6' ' ' VAL . 51.0 tp -54.12 -53.58 51.26 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -47.03 -56.92 5.62 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 123.216 1.484 . . . . 0.0 110.462 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -52.74 -47.22 67.53 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.559 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -68.1 -28.73 67.6 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.481 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' ' NH1' ' A' ' 44' ' ' ARG . . . -68.62 77.23 0.29 Allowed 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.173 0.987 . . . . 0.0 110.905 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -96.96 0.89 49.62 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.1 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.3 t -120.79 158.93 26.49 Favored 'General case' 0 N--CA 1.503 2.195 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.324 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -60.14 -35.17 74.7 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.19 -50.71 66.43 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.624 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -70.26 -19.47 63.11 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.16 -1.416 . . . . 0.0 111.584 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -85.43 -38.7 18.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.417 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 4.0 mt-30 -72.95 -44.86 60.64 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.931 0.872 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.0 m -59.72 -54.33 47.55 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.91 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.598 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.772 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.8 t -56.22 -42.57 77.48 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.586 0.708 . . . . 0.0 109.211 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 45' ' ' GLN . 68.2 m-80 -59.91 -37.46 79.51 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.649 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.65 -60.9 3.08 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 125.135 1.522 . . . . 0.0 111.475 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 52' ' ' LYS . 2.5 pp -60.58 -38.84 85.92 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.475 ' N ' HD12 ' A' ' 51' ' ' LEU . 38.4 mttt -57.63 -57.69 11.61 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.592 0.633 . . . . 0.0 111.739 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.34 -36.32 57.46 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 120.311 -0.947 . . . . 0.0 110.747 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG21 HD11 ' A' ' 14' ' ' LEU . 73.9 mt -70.27 -66.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 124.481 0.753 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.65 -39.98 5.5 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.711 0.767 . . . . 0.0 110.157 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -51.25 -27.48 9.31 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.32 -8.36 57.65 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.4 mm -81.92 108.09 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 117.929 0.865 . . . . 0.0 108.75 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -71.66 -55.59 7.44 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.271 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.84 51.49 1.55 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.353 -1.339 . . . . 0.0 110.522 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -62.18 141.09 58.37 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 114.869 -1.06 . . . . 0.0 108.529 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.6 t-20 -112.32 122.7 48.47 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.042 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -79.51 -39.41 32.07 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -49.07 -49.82 39.68 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 120.922 0.392 . . . . 0.0 111.916 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 81.6 m-20 -75.16 -49.65 18.83 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.331 -0.548 . . . . 0.0 109.971 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.575 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.99 -39.97 28.76 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 120.863 0.363 . . . . 0.0 111.542 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.0 ttt-85 -84.89 -20.34 30.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.568 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.6 m -84.76 -0.09 52.5 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 120.462 -0.495 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.593 HD13 ' HB3' ' A' ' 13' ' ' CYS . 68.0 mt -71.87 -63.76 1.23 Allowed Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.9 Cg_endo -57.06 -44.34 45.11 Favored 'Trans proline' 0 C--N 1.318 -1.056 0 N-CA-C 116.751 1.789 . . . . 0.0 116.751 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 69.7 Cg_endo -67.68 -24.19 41.57 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.027 1.818 . . . . 0.0 111.775 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.76 -71.11 0.23 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.163 0.506 . . . . 0.0 111.317 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.8 m -69.86 -44.16 70.39 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.708 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.2 45.83 0.78 Allowed Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.211 -2.356 . . . . 0.0 107.211 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.28 -36.35 6.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.2 t30 55.19 80.82 0.12 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.121 0.888 . . . . 0.0 112.244 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.72 153.95 38.07 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 47.5 Cg_endo -89.91 12.52 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.722 1.38 . . . . 0.0 109.887 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.3 OUTLIER -170.32 151.92 3.94 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.646 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.0 t -143.63 -163.86 1.75 Allowed 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.443 HG21 ' CD2' ' A' ' 14' ' ' LEU . 43.3 mm -77.5 73.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -162.31 169.73 20.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.082 -1.011 . . . . 0.0 109.479 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.5 mt -113.9 51.09 0.88 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.92 25.4 9.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.662 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -140.12 165.82 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.611 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.79 -38.2 5.44 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.969 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.44 ' HA ' ' CG2' ' A' ' 90' ' ' VAL . 51.5 m 62.02 19.07 10.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 125.531 1.77 . . . . 0.0 109.936 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p -86.75 -47.04 9.45 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.19 0.519 . . . . 0.0 110.554 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.31 44.52 2.09 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.396 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 87' ' ' CYS . 27.6 m . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 117.129 -1.415 . . . . 0.0 109.058 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 2' ' ' ASP 0.298 1.2 m-20 -98.33 54.11 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 123.544 1.64 . . . . 0.0 110.439 -179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.4 t 47.5 36.33 5.07 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-N 113.219 -1.81 . . . . 0.0 111.909 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.95 -34.45 21.41 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -110.97 -31.89 6.99 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.414 0.626 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.55 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 20.7 t -61.44 -35.56 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.604 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.67 -51.05 52.89 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.209 1.481 . . . . 0.0 110.779 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -71.4 -22.67 61.83 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.137 -1.392 . . . . 0.0 111.412 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.0 mt -78.33 -36.52 46.19 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 121.638 -0.664 . . . . 0.0 111.277 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 32.0 m -89.48 -12.83 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-O 121.647 0.737 . . . . 0.0 110.929 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.62 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -62.39 -42.99 83.49 Favored Pre-proline 0 N--CA 1.5 2.025 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 60.3 Cg_endo -59.35 -32.8 97.27 Favored 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.906 1.738 . . . . 0.0 114.919 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 31' ' ' VAL . 92.1 m -73.28 -23.75 60.34 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.441 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.461 HD11 HG21 ' A' ' 54' ' ' ILE . 33.0 mt -61.39 -32.2 72.13 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.357 0.599 . . . . 0.0 111.6 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.1 t -53.24 -23.63 9.26 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.659 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -96.18 -44.39 7.31 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 t -55.18 -31.17 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.8 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.26 -22.89 66.92 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.9 -1.125 . . . . 0.0 112.112 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.96 40.16 2.03 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.05 -170.29 11.83 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.36 135.11 28.27 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.617 1.545 . . . . 0.0 109.52 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.42 -158.25 30.62 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.9 Cg_endo -71.11 -62.34 0.04 OUTLIER 'Cis proline' 0 C--N 1.312 -1.345 0 O-C-N 123.763 1.402 . . . . 0.0 112.702 0.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.416 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 54.2 p 172.73 165.08 0.12 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.138 0.899 . . . . 0.0 108.836 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.5 -6.95 72.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.75 -19.28 16.81 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.94 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.455 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.6 t -57.32 -37.06 71.91 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.117 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.0 m -84.34 -61.88 1.69 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.446 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.66 -34.45 72.85 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.357 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.26 -52.92 11.42 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.891 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.616 HG21 ' SG ' ' A' ' 13' ' ' CYS . 44.3 t -72.45 -37.09 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 118.861 -1.135 . . . . 0.0 109.979 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -53.29 -47.93 68.77 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -60.08 -49.68 76.7 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.009 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.6 tp -53.5 -59.4 4.64 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.702 0.763 . . . . 0.0 109.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.441 ' HD1' ' C ' ' A' ' 35' ' ' HIS . 1.0 OUTLIER -49.32 -54.45 17.03 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.041 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -56.96 -44.84 82.99 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.544 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -63.85 -37.46 87.45 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.702 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.08 75.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.1 mtm-85 -95.52 2.47 54.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.601 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -114.36 -174.61 2.51 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -87.45 -34.11 18.82 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -44.06 95.28 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 119.089 -0.482 . . . . 0.0 112.077 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -72.48 -20.48 61.37 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 117.618 -1.633 . . . . 0.0 111.885 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.445 HH21 ' C ' ' A' ' 90' ' ' VAL . 1.3 mtp180 -86.88 -35.24 19.1 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.17 -42.12 32.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.0 m -63.62 -53.53 50.07 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.847 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . . . -54.63 -40.49 68.99 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.096 -1.042 . . . . 0.0 109.777 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.9 t -52.36 -51.75 57.16 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.471 0.653 . . . . 0.0 109.694 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -52.38 -35.54 51.7 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.651 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.55 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 71.9 m -59.14 -47.13 86.41 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.514 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.0 mp -76.54 -50.05 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.978 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -55.4 -50.68 69.11 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.682 0.754 . . . . 0.0 109.44 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.36 95.61 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG21 HD11 ' A' ' 14' ' ' LEU . 62.8 mt -66.13 -63.31 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.527 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -43.57 -41.12 4.37 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.232 1.015 . . . . 0.0 111.097 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -55.26 -25.93 36.73 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.48 25.31 27.29 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.138 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.2 mt -117.93 -41.04 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 54.3 t60 71.56 -65.4 0.35 Allowed 'General case' 0 N--CA 1.51 2.528 0 O-C-N 123.388 0.43 . . . . 0.0 109.908 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -87.96 83.11 7.09 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.8 mt -108.67 173.09 6.47 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 22.8 t-20 -120.43 110.4 16.46 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -74.15 -34.88 64.0 Favored 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.392 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -53.11 -47.67 68.43 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.252 0.345 . . . . 0.0 110.593 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.9 m-20 -74.13 -46.02 45.17 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.08 -45.63 32.79 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-O 121.44 0.638 . . . . 0.0 111.289 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' NH1' ' OE1' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -77.03 -22.25 53.32 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.573 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.9 m -82.76 -3.88 57.17 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.567 HD11 ' CG2' ' A' ' 17' ' ' VAL . 73.1 mt -73.34 -59.83 1.92 Allowed Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 40.2 Cg_endo -58.6 -42.18 56.89 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 N-CA-C 117.08 1.915 . . . . 0.0 117.08 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 58.8 Cg_endo -61.06 -57.53 0.6 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.716 1.61 . . . . 0.0 112.171 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -56.38 -32.5 64.84 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.847 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 72' ' ' LYS . 9.2 t -75.69 -50.42 15.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.558 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.01 39.09 3.9 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 106.033 -2.827 . . . . 0.0 106.033 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.35 -38.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 CA-C-N 114.583 -0.809 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.7 t30 56.38 79.23 0.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 123.494 0.496 . . . . 0.0 112.193 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -79.98 151.47 73.31 Favored Pre-proline 0 N--CA 1.506 2.341 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.877 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.503 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 90.3 Cg_endo -69.86 -11.75 31.32 Favored 'Trans proline' 0 C--N 1.322 -0.829 0 C-N-CA 122.026 1.817 . . . . 0.0 111.197 175.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 47' ' ' ALA . 0.7 OUTLIER -164.83 167.47 18.76 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 118.554 0.616 . . . . 0.0 110.668 179.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 t -144.9 -151.69 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.3 mp -84.34 73.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.3 t -154.77 -168.48 2.91 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.355 -0.841 . . . . 0.0 109.778 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -138.68 43.24 2.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 123.993 0.808 . . . . 0.0 110.22 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.92 -33.55 6.26 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.594 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.626 HD12 ' H ' ' A' ' 85' ' ' ILE . 4.4 mp -67.91 157.96 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 123.89 0.744 . . . . 0.0 110.154 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.91 -40.51 12.34 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.358 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 82.4 m 56.6 21.5 5.82 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.5 t -95.56 -42.57 8.36 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 -135.9 53.46 1.95 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.213 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.445 ' C ' HH21 ' A' ' 44' ' ' ARG . 31.7 m . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 123.386 1.565 . . . . 0.0 107.531 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 91.2 mt . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.4 138.98 30.97 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.846 0.831 . . . . 0.0 109.141 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.8 t -67.04 -17.32 64.85 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.388 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.86 -35.23 67.32 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.616 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -90.86 -43.2 10.19 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.995 0.902 . . . . 0.0 109.666 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 47' ' ' ALA . 40.2 t -60.23 -33.16 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.422 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' CG ' HH12 ' A' ' 11' ' ' ARG . 0.5 OUTLIER -54.23 -45.18 72.23 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.848 0.832 . . . . 0.0 110.61 179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -26.39 63.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.694 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 mt -73.88 -38.25 64.47 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.445 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 HD11 ' A' ' 51' ' ' LEU . 35.6 m -89.16 -11.45 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.193 0.521 . . . . 0.0 111.57 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.61 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -63.0 -42.31 76.44 Favored Pre-proline 0 N--CA 1.499 1.982 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 62.0 Cg_endo -59.83 -32.43 95.39 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.473 1.448 . . . . 0.0 114.366 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.627 ' SG ' HG21 ' A' ' 31' ' ' VAL . 89.7 m -73.38 -24.57 60.33 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.044 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.607 HD22 HD13 ' A' ' 81' ' ' ILE . 27.7 mt -61.59 -31.87 71.95 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.99 0.9 . . . . 0.0 110.424 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.94 -24.14 6.0 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -96.2 -43.63 7.64 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.127 0.965 . . . . 0.0 108.772 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 22.6 t -53.87 -28.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 114.142 -1.39 . . . . 0.0 111.732 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -60.78 -31.54 70.91 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.664 -0.648 . . . . 0.0 111.657 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.52 1.65 Allowed Glycine 0 N--CA 1.501 2.985 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.49 -165.77 10.51 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -72.48 139.84 32.17 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.477 1.451 . . . . 0.0 109.627 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 -161.72 32.67 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 78.5 Cg_endo -75.99 -60.33 0.08 OUTLIER 'Cis proline' 0 C--N 1.307 -1.651 0 O-C-N 123.203 1.107 . . . . 0.0 112.554 3.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.435 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.7 p 171.63 163.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 124.339 1.025 . . . . 0.0 108.678 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.05 -4.4 62.84 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.881 -2.087 . . . . 0.0 107.881 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -96.72 -25.27 15.59 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 69' ' ' ILE . 44.7 t -54.75 -48.16 72.97 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.525 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 56.5 m -75.43 -61.08 2.03 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 117.508 -1.677 . . . . 0.0 112.17 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.35 -37.79 75.9 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 119.149 0.886 . . . . 0.0 110.378 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.08 -51.79 31.64 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG21 ' SG ' ' A' ' 13' ' ' CYS . 22.0 t -76.25 -35.37 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.684 -1.206 . . . . 0.0 110.984 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -56.63 -45.51 81.5 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.19 -54.6 45.12 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.41 -54.74 23.67 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.882 0.848 . . . . 0.0 110.708 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -55.56 -54.3 45.68 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.875 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -51.71 -36.05 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.209 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -91.58 26.38 2.34 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.706 -0.798 . . . . 0.0 113.004 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.66 57.03 1.04 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.016 0.913 . . . . 0.0 109.929 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -90.86 -12.03 37.48 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.559 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -99.27 143.2 29.8 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 118.704 -1.198 . . . . 0.0 112.243 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -47.39 -40.77 18.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.362 0.414 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.89 -29.18 50.08 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.92 -32.66 65.46 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' NH2' ' HB3' ' A' ' 88' ' ' SER . 26.7 ttp180 -77.1 -53.17 8.12 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.625 HE21 ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.7 -45.52 58.45 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 122.71 1.243 . . . . 0.0 109.029 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 m -52.92 -65.22 0.6 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.77 -39.99 72.0 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.938 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' ' CE2' ' A' ' 79' ' ' TYR . 37.3 m -55.31 -40.94 71.73 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -68.48 -29.95 68.68 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.655 -1.618 . . . . 0.0 112.302 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 59.9 m -59.97 -52.35 65.79 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.007 0.908 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 51' ' ' LEU . 6.6 mp -59.11 -40.67 86.09 Favored 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 119.384 -0.926 . . . . 0.0 110.844 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -56.97 -59.11 5.55 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 124.056 0.847 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.36 -41.25 54.82 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.412 HG12 HH11 ' A' ' 11' ' ' ARG . 76.1 mt -62.03 -65.27 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 124.385 0.697 . . . . 0.0 111.387 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.64 7.3 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 122.88 1.324 . . . . 0.0 110.863 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -67.09 -9.37 38.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.43 33.0 3.4 Favored Glycine 0 N--CA 1.492 2.417 0 CA-C-N 118.44 0.563 . . . . 0.0 112.316 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 mm -106.05 128.0 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -72.6 -38.07 67.93 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 123.467 0.479 . . . . 0.0 109.932 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -132.62 71.88 1.48 Allowed 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.218 0.532 . . . . 0.0 110.401 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tt -75.22 141.31 43.58 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 37.9 t-20 -116.79 99.79 7.35 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -60.33 -28.2 67.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.594 0.559 . . . . 0.0 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -41.05 86.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.302 1.048 . . . . 0.0 109.76 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -76.46 -49.91 15.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.67 -38.74 33.88 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 122.134 0.968 . . . . 0.0 111.624 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -77.45 -27.24 52.09 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.336 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.1 t -82.09 -7.18 59.61 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' SG ' ' A' ' 27' ' ' CYS . 86.8 mt -74.22 -56.36 2.6 Favored Pre-proline 0 N--CA 1.501 2.08 0 O-C-N 120.705 -1.247 . . . . 0.0 110.396 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 37.0 Cg_endo -56.8 -43.38 55.14 Favored 'Trans proline' 0 CA--C 1.552 1.407 0 N-CA-C 117.159 1.946 . . . . 0.0 117.159 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 66.8 Cg_endo -61.86 -58.65 0.36 Allowed 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 120.967 1.111 . . . . 0.0 113.047 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 12.5 pttp -55.51 -37.32 67.74 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.925 0.869 . . . . 0.0 111.55 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.571 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 15.8 t -60.4 -57.97 10.47 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.652 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.96 14.48 10.04 Favored Glycine 0 N--CA 1.5 2.922 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.108 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.3 m -113.39 -27.56 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.133 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.5 t30 52.95 80.05 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.23 156.59 68.23 Favored Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.406 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.72 3.2 6.83 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 121.773 1.648 . . . . 0.0 110.075 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' HA ' HG21 ' A' ' 85' ' ' ILE . 37.2 p90 -171.53 134.22 0.84 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.672 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.52 173.55 7.61 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.607 HD13 HD22 ' A' ' 14' ' ' LEU . 2.3 pt -78.05 55.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.91 0.862 . . . . 0.0 111.897 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.29 30.69 4.17 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.556 -1.34 . . . . 0.0 110.796 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.3 mt 36.68 34.53 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.66 22.53 11.98 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 123.646 0.591 . . . . 0.0 110.29 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG21 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -149.31 156.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 123.318 0.386 . . . . 0.0 111.247 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' VAL . 4.4 t70 -123.59 -20.08 5.63 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 124.401 1.063 . . . . 0.0 111.863 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 96.1 m 68.87 -55.46 0.54 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.585 ' HB3' ' NH2' ' A' ' 44' ' ' ARG . 3.1 t 175.31 -51.7 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.625 ' N ' HE21 ' A' ' 45' ' ' GLN . 15.5 ttm-85 -161.87 40.92 0.13 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 86' ' ' ASP . 11.5 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 115.825 -2.036 . . . . 0.0 106.588 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -88.25 132.07 34.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.333 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 t -61.76 -19.67 62.72 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.412 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.41 63.54 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -90.53 -41.31 11.47 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.579 0.704 . . . . 0.0 109.407 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.5 t -63.16 -32.56 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.098 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 11.7 t70 -54.2 -40.51 67.66 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.662 1.22 . . . . 0.0 110.532 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 11' ' ' ARG . 8.4 t -78.61 -25.09 45.08 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.455 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.9 mt -72.86 -42.6 63.52 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.754 -0.591 . . . . 0.0 110.694 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.1 -17.32 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.707 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.594 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -48.05 -50.21 55.81 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.25 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 56.5 Cg_endo -57.66 -27.44 77.35 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 C-N-CA 121.626 1.55 . . . . 0.0 113.264 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 31' ' ' VAL . 64.1 m -82.08 -23.34 35.82 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 118.288 -1.365 . . . . 0.0 110.248 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 54' ' ' ILE . 10.5 mp -62.9 -29.56 70.86 Favored 'General case' 0 N--CA 1.512 2.634 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.36 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 23' ' ' PRO . 88.4 p -53.79 -23.64 12.75 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.921 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -97.65 -43.38 7.22 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.037 0.922 . . . . 0.0 109.058 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.9 t -55.36 -29.81 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.631 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -65.75 -23.78 66.81 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.346 -0.846 . . . . 0.0 111.889 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.9 42.63 1.52 Allowed Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.42 -170.13 11.95 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -70.45 142.48 44.98 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.638 1.558 . . . . 0.0 109.627 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.99 -159.36 28.29 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 24' ' ' SER . 91.9 Cg_endo -71.52 -66.17 0.03 OUTLIER 'Cis proline' 0 C--N 1.308 -1.569 0 O-C-N 123.362 1.191 . . . . 0.0 112.515 3.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.46 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.3 p 175.17 166.27 0.3 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 124.817 1.323 . . . . 0.0 109.347 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.01 -3.59 75.32 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.569 ' CA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -98.77 -23.9 15.23 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 69' ' ' ILE . 35.1 t -54.85 -35.84 64.41 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.78 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -83.49 -59.95 2.29 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.781 -1.168 . . . . 0.0 111.308 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -38.92 85.6 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.978 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.58 -50.03 56.91 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.908 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.7 t -77.6 -38.53 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.391 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -53.66 -43.49 68.85 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -59.31 -57.37 13.31 Favored 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 122.007 0.908 . . . . 0.0 108.937 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.1 tp -47.78 -55.94 8.5 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 123.822 1.772 . . . . 0.0 110.995 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.462 ' NE2' ' HD3' ' A' ' 78' ' ' PRO . 20.0 t-160 -50.6 -56.72 10.47 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 113.159 -1.837 . . . . 0.0 109.946 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.09 -32.61 64.3 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.841 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -72.98 -24.35 60.76 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.243 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HD2' ' A' ' 44' ' ' ARG . . . -77.07 76.92 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.587 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -96.32 -26.13 15.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.9 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -104.5 147.22 27.84 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.17 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -51.47 -35.54 40.37 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.386 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.5 t -73.81 -28.95 61.89 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.414 -0.514 . . . . 0.0 111.796 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -73.28 -32.16 64.49 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.088 0.243 . . . . 0.0 110.779 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 2.2 mpt_? -74.89 -52.94 9.99 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -49.94 -43.69 50.09 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.694 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.9 m -57.72 -62.16 2.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.288 1.042 . . . . 0.0 111.508 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -58.15 -41.9 84.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 118.822 -1.151 . . . . 0.0 111.299 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.8 t -55.07 -41.36 71.43 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.973 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -59.72 -39.82 85.95 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.675 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 72.9 m -52.99 -55.59 22.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 124.758 1.287 . . . . 0.0 110.358 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.5 mp -60.23 -44.72 94.97 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.058 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -57.52 -58.41 8.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 123.813 0.696 . . . . 0.0 109.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.72 -48.59 56.2 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.726 -1.749 . . . . 0.0 108.726 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 14' ' ' LEU . 54.4 mt -54.98 -65.82 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 122.547 1.165 . . . . 0.0 111.767 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.69 -34.45 11.96 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.931 -1.032 . . . . 0.0 111.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -65.27 -31.45 72.61 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.67 -28.28 27.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -74.13 142.82 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.148 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -104.26 -44.25 5.01 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.323 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -93.95 67.76 3.75 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 tt -89.88 137.47 32.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -114.85 99.77 7.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.022 0.915 . . . . 0.0 110.277 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -34.35 69.52 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.825 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -50.53 -51.17 50.18 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.767 0.794 . . . . 0.0 110.797 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 95.8 m-20 -73.85 -42.96 60.08 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.386 -1.325 . . . . 0.0 109.896 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.71 -40.76 29.5 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 121.898 -0.501 . . . . 0.0 110.862 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.5 ttm105 -77.36 -28.16 52.85 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.597 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 38.2 t -73.94 -17.1 61.06 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.739 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 13' ' ' CYS . 78.1 mt -64.65 -62.81 4.4 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.668 -0.645 . . . . 0.0 111.384 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.5 Cg_endo -56.07 -43.34 57.54 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 N-CA-C 116.827 1.818 . . . . 0.0 116.827 -177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.7 Cg_endo -60.76 -56.38 1.0 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.585 1.523 . . . . 0.0 112.821 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.42 ' HE2' ' CD ' ' A' ' 23' ' ' PRO . 17.2 pttp -59.6 -35.01 73.48 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.184 -1.007 . . . . 0.0 112.01 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.7 t -69.09 -56.08 8.79 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.177 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.53 18.45 9.6 Favored Glycine 0 N--CA 1.501 2.978 0 C-N-CA 120.159 -1.02 . . . . 0.0 112.57 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.1 m -112.22 -25.22 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.377 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.4 t30 55.2 93.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.4 mp -85.07 153.86 60.16 Favored Pre-proline 0 N--CA 1.506 2.352 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.15 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.493 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 60.0 Cg_endo -75.88 -10.54 19.84 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 121.586 1.524 . . . . 0.0 110.099 176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.8 p90 -160.26 162.8 33.74 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.092 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.2 t -141.0 -162.69 1.4 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 32.2 mm -84.79 74.8 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -146.95 177.46 9.11 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.0 mp -115.25 44.15 1.88 Allowed 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.927 0.87 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -111.18 -28.35 8.31 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.002 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.498 HD12 ' H ' ' A' ' 85' ' ' ILE . 3.9 mp -89.33 163.26 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.817 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.41 -24.62 13.04 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.432 1.082 . . . . 0.0 113.611 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 62.7 m 55.32 16.8 1.84 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 123.86 0.725 . . . . 0.0 112.366 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 p -99.72 -32.09 11.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.602 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.0 ttm-85 -105.8 -44.32 4.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.159 0.912 . . . . 0.0 111.88 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 114.568 -2.634 . . . . 0.0 109.744 -179.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.92 143.94 44.74 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.143 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.24 -18.95 52.37 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.234 -0.586 . . . . 0.0 111.431 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.9 -47.29 80.39 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -76.86 -43.42 36.18 Favored 'General case' 0 N--CA 1.506 2.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 108.222 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 47' ' ' ALA . 48.8 t -55.36 -36.07 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 23.3 m-20 -53.15 -64.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.403 0.621 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 p -57.09 -19.95 22.49 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.64 -0.663 . . . . 0.0 112.531 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 34' ' ' LEU . 72.0 mt -84.88 -38.67 19.16 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 121.911 -0.493 . . . . 0.0 111.636 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG11 HD11 ' A' ' 51' ' ' LEU . 14.2 m -96.4 -21.65 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.882 0.849 . . . . 0.0 112.386 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.616 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mmm180 -63.7 -39.87 51.3 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.9 Cg_endo -61.06 -26.14 82.45 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.211 1.274 . . . . 0.0 113.45 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.632 ' SG ' HG21 ' A' ' 31' ' ' VAL . 55.6 m -76.85 -25.5 53.22 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 118.731 -1.187 . . . . 0.0 110.031 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' A' ' 54' ' ' ILE . 5.5 mp -59.57 -28.41 67.12 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.606 -0.684 . . . . 0.0 111.376 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.1 m -49.99 -27.43 5.43 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.992 0.901 . . . . 0.0 111.37 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.28 -42.19 8.66 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.122 0.963 . . . . 0.0 108.578 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.617 HG22 ' HA ' ' A' ' 66' ' ' ALA . 21.6 t -54.57 -32.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.657 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -68.04 -20.35 64.97 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.122 -0.986 . . . . 0.0 112.482 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.48 2.81 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.14 -166.84 10.91 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -69.29 128.71 16.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.772 1.648 . . . . 0.0 109.841 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.97 -161.74 35.29 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.48 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 95.1 Cg_endo -70.29 -64.83 0.03 OUTLIER 'Cis proline' 0 C--N 1.314 -1.242 0 C-N-CA 123.509 -1.455 . . . . 0.0 111.48 3.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.428 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 36.9 p 178.69 170.45 0.84 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.068 0.855 . . . . 0.0 109.493 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -79.09 -2.41 87.07 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -107.67 -20.19 13.3 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.949 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' A' ' 69' ' ' ILE . 42.9 t -51.94 -40.83 61.42 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.21 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 15.5 m -80.67 -61.94 1.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.409 -1.316 . . . . 0.0 112.575 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -33.63 70.96 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.909 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.51 -52.92 9.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG21 ' SG ' ' A' ' 13' ' ' CYS . 25.3 t -73.95 -35.48 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.755 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -59.56 -41.16 89.5 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -66.88 -55.11 16.12 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.511 -0.875 . . . . 0.0 109.994 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HB2' HD13 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -51.43 -53.43 36.95 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.739 0.781 . . . . 0.0 110.259 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -52.98 58.89 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.895 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -39.38 89.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.116 0.885 . . . . 0.0 110.225 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -61.89 -39.94 93.7 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.372 0.606 . . . . 0.0 110.098 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.79 107.63 5.32 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.569 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.08 5.68 5.91 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.466 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 95.2 p -120.05 -168.28 1.59 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 123.911 0.757 . . . . 0.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -99.56 15.61 26.04 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.3 m -110.66 -42.73 3.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -71.59 -43.13 66.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.722 0.772 . . . . 0.0 111.857 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -70.08 -50.67 38.62 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.3 75.6 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.691 -0.803 . . . . 0.0 109.805 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.1 m -70.28 -54.34 13.06 Favored 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 118.138 -1.425 . . . . 0.0 109.449 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.68 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.77 -36.91 72.8 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.314 -1.354 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.463 ' HB3' HG21 ' A' ' 90' ' ' VAL . 21.3 m -57.27 -41.33 79.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -60.75 -44.15 97.07 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.856 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -51.01 -54.01 28.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.877 0.846 . . . . 0.0 110.768 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 51' ' ' LEU . 6.6 mp -65.2 -49.29 70.3 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.597 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -56.95 -49.49 75.51 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.38 97.71 Favored Glycine 0 N--CA 1.496 2.685 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CG2' HD21 ' A' ' 14' ' ' LEU . 67.8 mt -66.16 -66.36 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 123.894 0.408 . . . . 0.0 111.298 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.89 -36.54 5.46 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.536 1.16 . . . . 0.0 111.028 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -62.06 -29.26 70.17 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.479 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.52 27.78 17.19 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.913 -1.137 . . . . 0.0 111.216 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.43 141.69 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -92.69 -54.74 3.64 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -92.21 81.67 5.0 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.93 1.348 . . . . 0.0 108.842 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 tt -92.3 125.78 37.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.542 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 29.4 t-20 -103.91 109.55 21.34 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.995 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -71.56 -33.16 68.87 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.192 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.9 -48.23 78.66 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.339 0.59 . . . . 0.0 110.063 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 88.8 m-20 -70.13 -52.72 21.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.956 -0.465 . . . . 0.0 110.331 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -49.89 -40.55 43.33 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.89 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.0 ttt-85 -79.57 -21.59 44.89 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.326 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.6 m -83.15 -5.54 59.16 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.556 ' HB ' ' CD ' ' A' ' 70' ' ' PRO . 48.2 mt -71.64 -59.34 3.1 Favored Pre-proline 0 N--CA 1.506 2.332 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.556 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 31.1 Cg_endo -54.57 -45.74 38.66 Favored 'Trans proline' 0 N--CA 1.485 1.012 0 N-CA-C 117.476 2.068 . . . . 0.0 117.476 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.4 Cg_endo -60.79 -55.1 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.267 1.978 . . . . 0.0 113.107 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -59.61 -38.46 81.35 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.01 0.818 . . . . 0.0 110.904 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.97 -58.03 4.68 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.018 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.08 34.69 3.14 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.4 m -119.13 -30.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 55.84 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 124.405 1.066 . . . . 0.0 111.429 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 mp -88.91 151.3 47.05 Favored Pre-proline 0 N--CA 1.503 2.212 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.74 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -81.73 -1.57 10.99 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.744 1.63 . . . . 0.0 110.753 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' HA ' HG13 ' A' ' 85' ' ' ILE . 45.2 p90 -169.22 133.85 1.46 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -118.94 -157.67 0.7 Allowed 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.1 mm -83.29 72.46 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 39.1 t -159.61 179.87 8.5 Favored 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.49 ' N ' ' OG ' ' A' ' 82' ' ' SER . 31.0 mt -118.95 30.06 7.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.95 33.76 5.48 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.879 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -144.42 152.18 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.32 -179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.04 101.41 7.4 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.527 1.142 . . . . 0.0 110.935 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.414 ' SG ' ' CG ' ' A' ' 79' ' ' TYR . 68.6 m -59.21 -52.57 65.13 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t 169.45 -57.68 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.61 41.09 0.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 48' ' ' CYS . 7.2 p . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.44 HG23 ' CB ' ' A' ' 46' ' ' SER . 16.6 tt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.0 41.6 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.221 0.534 . . . . 0.0 111.033 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.8 t 49.42 36.18 9.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.533 1.158 . . . . 0.0 111.061 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.01 -30.64 30.98 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -114.77 -35.83 4.7 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.983 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 40.8 t -57.21 -40.33 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.425 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -50.38 -43.54 54.46 Favored 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 121.433 0.635 . . . . 0.0 111.399 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.3 t -79.84 -19.46 48.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.474 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 mt -79.91 -36.85 35.82 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.694 -0.629 . . . . 0.0 110.505 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -84.47 -22.31 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 CA-C-O 121.94 0.876 . . . . 0.0 111.746 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.592 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -54.03 -49.44 89.81 Favored Pre-proline 0 N--CA 1.498 1.967 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 67.5 Cg_endo -60.21 -29.94 90.13 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 121.831 1.688 . . . . 0.0 114.87 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' SG ' HG21 ' A' ' 31' ' ' VAL . 62.9 m -76.18 -21.94 55.92 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 118.34 -1.344 . . . . 0.0 111.316 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.9 mp -63.43 -31.01 72.05 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.453 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 67.4 m -52.83 -23.32 6.72 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.001 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -95.49 -45.47 7.07 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 69' ' ' ILE . 23.3 t -52.65 -32.94 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 CA-C-N 114.476 -1.238 . . . . 0.0 111.878 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -66.15 -21.99 66.36 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.412 -0.805 . . . . 0.0 112.251 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.38 3.22 Favored Glycine 0 N--CA 1.5 2.966 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.83 -165.84 10.78 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.04 125.27 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.7 1.6 . . . . 0.0 109.863 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.15 -162.68 35.51 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 94.4 Cg_endo -73.16 -62.96 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 O-C-N 123.618 1.325 . . . . 0.0 111.765 1.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 57.0 p 171.97 164.05 0.1 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 124.472 1.108 . . . . 0.0 109.05 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.75 -6.98 68.42 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 107.198 -2.361 . . . . 0.0 107.198 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -98.83 -16.27 18.94 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.37 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' SG ' HG23 ' A' ' 69' ' ' ILE . 37.2 t -59.35 -40.61 86.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.219 -0.993 . . . . 0.0 109.011 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 20.6 m -80.25 -59.71 2.6 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 118.139 -1.425 . . . . 0.0 110.79 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.37 -46.42 73.01 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.405 -0.809 . . . . 0.0 110.867 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.99 -51.66 51.42 Favored Glycine 0 N--CA 1.487 2.036 0 CA-C-N 113.507 -1.679 . . . . 0.0 113.256 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' SG ' ' A' ' 13' ' ' CYS . 21.5 t -76.95 -34.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.785 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.73 -43.76 80.97 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.15 -48.25 74.2 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.977 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 34' ' ' LEU . 1.4 tt -49.5 -61.97 1.81 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.087 0.946 . . . . 0.0 110.893 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -48.37 -53.34 17.95 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.257 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -55.92 -39.86 72.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.628 1.205 . . . . 0.0 110.562 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -67.96 -48.17 66.59 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -76.3 70.78 2.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.238 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -95.18 1.44 54.75 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 118.872 -1.131 . . . . 0.0 112.245 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.7 m -112.53 157.33 21.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.066 0.853 . . . . 0.0 109.685 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -67.21 -13.68 62.19 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.1 t -87.61 -26.53 23.02 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 118.31 -0.853 . . . . 0.0 109.22 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.2 t70 -79.92 -22.68 42.44 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.647 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.0 mtt85 -77.84 -45.52 24.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -59.16 -39.13 81.52 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.978 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 1' ' ' ILE . 40.4 m -71.32 -56.04 6.81 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.656 -1.217 . . . . 0.0 109.181 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.41 63.84 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.919 0.866 . . . . 0.0 110.007 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.697 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 41.7 t -54.8 -51.03 67.06 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.638 -0.663 . . . . 0.0 109.312 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -52.18 -37.58 55.17 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.62 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.514 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 85.8 m -54.66 -59.7 4.35 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.803 1.287 . . . . 0.0 109.216 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 24.3 mt -61.38 -52.35 64.96 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.697 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 50.8 mtpt -53.58 -54.1 42.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.499 1.124 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.44 -42.33 83.19 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' A' ' 14' ' ' LEU . 48.1 mt -66.78 -62.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.729 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.33 -47.01 13.27 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.418 0.628 . . . . 0.0 109.859 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -54.43 -29.17 48.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.78 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.96 -18.2 75.44 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.2 mt -81.88 164.07 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -96.41 -58.81 1.97 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.398 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -137.75 75.88 1.55 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.97 -167.51 0.21 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 108.741 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.8 t-20 -118.64 126.07 51.13 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.253 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -83.33 -34.5 25.66 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.43 -43.99 92.99 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.26 1.029 . . . . 0.0 110.135 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 63.3 m-20 -68.92 -51.68 37.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.945 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -47.49 -43.51 24.53 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.019 -0.425 . . . . 0.0 111.403 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 ttt-85 -79.27 -20.42 48.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.923 0.765 . . . . 0.0 109.921 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 6.3 t -77.38 -16.08 59.05 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 119.154 -0.45 . . . . 0.0 111.924 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' A' ' 13' ' ' CYS . 67.6 mt -64.46 -61.08 7.12 Favored Pre-proline 0 N--CA 1.503 2.206 0 CA-C-N 118.074 0.397 . . . . 0.0 111.489 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -55.85 -44.06 51.12 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.485 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 73.9 Cg_endo -62.53 -56.0 0.77 Allowed 'Trans proline' 0 N--CA 1.486 1.076 0 C-N-CA 121.494 1.462 . . . . 0.0 113.158 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -58.57 -39.92 81.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 123.847 0.717 . . . . 0.0 111.108 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -65.84 -57.61 7.54 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.975 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.13 26.27 5.54 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.68 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 m -115.21 -22.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 4.9 t30 46.76 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 125.087 1.492 . . . . 0.0 112.965 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.24 157.69 47.45 Favored Pre-proline 0 N--CA 1.501 2.1 0 C-N-CA 119.585 -0.846 . . . . 0.0 109.07 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -81.76 -5.7 12.37 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.327 1.351 . . . . 0.0 108.969 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 85' ' ' ILE . 18.2 p90 -168.85 153.18 5.68 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.229 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.4 t -138.07 -153.86 0.5 Allowed 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 81' ' ' ILE . 2.1 mp -80.8 79.55 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.58 167.16 31.04 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.8 mt -115.52 35.61 4.33 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.19 -10.27 13.4 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 124.103 0.877 . . . . 0.0 111.344 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.599 HG21 ' HB3' ' A' ' 79' ' ' TYR . 3.6 mp -84.14 150.34 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.96 -37.43 12.86 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.902 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m 51.86 23.97 2.33 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.274 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.6 t -105.17 -23.36 12.92 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 119.133 -0.461 . . . . 0.0 109.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -137.21 34.64 2.55 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 115.938 -1.982 . . . . 0.0 108.627 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.39 142.97 51.02 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 46.2 t -76.54 67.59 2.72 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 123.21 1.481 . . . . 0.0 110.588 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.69 -35.47 3.03 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -100.89 -36.85 8.91 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.038 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 33.7 t -59.76 -30.29 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.157 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.44 -62.36 1.7 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-O 121.905 0.86 . . . . 0.0 110.673 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -60.26 -26.35 66.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.744 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.64 -43.51 65.99 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.429 -0.794 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.576 ' HB ' HD21 ' A' ' 51' ' ' LEU . 30.4 m -94.08 8.84 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 CA-C-O 121.773 0.797 . . . . 0.0 111.228 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.602 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -77.36 -33.36 1.05 Allowed Pre-proline 0 N--CA 1.501 2.075 0 N-CA-C 113.223 0.824 . . . . 0.0 113.223 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 69.6 Cg_endo -71.51 -25.55 21.04 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 121.243 1.295 . . . . 0.0 111.926 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -84.4 -9.67 58.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.421 -1.711 . . . . 0.0 112.326 179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 81' ' ' ILE . 13.2 mt -64.61 -31.48 72.72 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 121.72 0.771 . . . . 0.0 110.747 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -53.65 -31.93 49.5 Favored 'General case' 0 N--CA 1.509 2.501 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 65' ' ' ASN . 16.9 t80 -87.48 -44.48 11.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.509 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 66' ' ' ALA . 23.4 t -54.6 -35.13 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.815 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.71 -20.48 63.54 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.143 -0.973 . . . . 0.0 111.9 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.29 42.95 1.22 Allowed Glycine 0 N--CA 1.5 2.9 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.44 -174.32 13.53 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.92 142.58 47.62 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.337 1.358 . . . . 0.0 109.809 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.06 -158.64 27.79 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.69 -67.25 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.337 0 C-N-CA 124.056 -1.227 . . . . 0.0 110.99 5.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 62.4 p 172.17 150.53 0.06 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 124.239 0.962 . . . . 0.0 109.845 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -72.2 -5.65 62.98 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -91.88 -25.73 18.81 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 31' ' ' VAL . 37.7 t -57.56 -56.56 20.34 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.659 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 73.1 m -56.09 -18.62 10.25 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -92.36 -47.99 6.89 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.85 -36.79 65.75 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.797 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.446 HG21 ' SG ' ' A' ' 27' ' ' CYS . 71.0 t -79.64 -44.56 23.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.624 -0.927 . . . . 0.0 110.183 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.85 -44.74 91.07 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -53.43 -61.38 2.34 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.33 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.7 tp -46.63 -57.87 4.37 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.317 1.532 . . . . 0.0 109.444 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -48.63 -49.56 36.65 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 113.331 -1.759 . . . . 0.0 112.098 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -72.49 -30.18 64.3 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.85 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -71.11 -36.37 72.13 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.627 0.727 . . . . 0.0 109.122 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -73.69 81.61 1.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.817 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -93.23 -9.63 38.48 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.36 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.2 m -107.48 -175.24 2.73 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.458 0.647 . . . . 0.0 110.297 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -84.98 -28.83 25.52 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.74 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 t -72.54 -39.95 67.11 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.437 0.637 . . . . 0.0 111.577 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -67.41 -25.92 66.17 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.923 -179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 87' ' ' CYS . 3.5 ttp180 -84.41 -42.78 15.33 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.511 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -39.19 92.09 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.289 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -65.19 -58.8 5.08 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-O 122.098 0.951 . . . . 0.0 109.862 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.526 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.52 -40.33 71.66 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.26 -0.976 . . . . 0.0 111.411 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.628 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . 8.0 t -56.67 -39.14 73.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.489 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' ND2' HG23 ' A' ' 90' ' ' VAL . 6.4 m-80 -63.73 -33.13 74.97 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.186 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 64.5 m -59.56 -59.04 6.07 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.689 0.757 . . . . 0.0 109.454 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD21 ' HB ' ' A' ' 10' ' ' VAL . 12.8 mt -64.04 -47.68 79.28 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.204 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -65.08 -50.32 66.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.08 52.59 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG21 HD11 ' A' ' 14' ' ' LEU . 59.1 mt -58.8 -67.77 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 CA-C-O 121.736 0.779 . . . . 0.0 110.995 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.97 -48.17 5.88 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 114.469 -1.242 . . . . 0.0 109.719 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -34.25 14.97 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.02 -26.98 32.58 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.14 145.58 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -109.1 -47.19 3.46 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.259 0.552 . . . . 0.0 110.026 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.62 69.28 5.72 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.429 HD21 HG22 ' A' ' 81' ' ' ILE . 14.3 tp -105.08 154.34 20.29 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 25.2 t-20 -114.53 118.95 35.19 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.035 0.445 . . . . 0.0 110.732 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.48 -34.39 65.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.283 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.74 -47.15 67.59 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.544 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.447 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 89.9 m-20 -71.28 -53.0 15.8 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.524 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.83 -43.66 18.67 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 122.704 1.24 . . . . 0.0 109.554 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 13.9 ttt180 -75.44 -30.08 59.89 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.698 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 55.5 m -80.62 2.39 25.92 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 13' ' ' CYS . 54.6 mt -79.97 -60.68 0.49 Allowed Pre-proline 0 N--CA 1.506 2.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.501 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 54.1 Cg_endo -59.05 -41.22 63.27 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 CA-C-O 116.405 -1.581 . . . . 0.0 116.134 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 63.3 Cg_endo -66.01 -13.84 41.72 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.471 2.114 . . . . 0.0 112.494 -178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 69' ' ' ILE . 20.1 ptmt -107.94 -38.38 5.83 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.248 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 37.5 t -56.05 -51.62 67.18 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.16 8.43 17.34 Favored Glycine 0 N--CA 1.504 3.19 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.967 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -115.8 -17.78 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 45.58 78.25 0.07 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.169 0.985 . . . . 0.0 113.646 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.19 150.72 91.95 Favored Pre-proline 0 N--CA 1.499 2.004 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.273 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -82.73 -0.35 10.05 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.36 1.373 . . . . 0.0 110.078 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.628 ' CD2' ' HA ' ' A' ' 48' ' ' CYS . 30.4 p90 -169.83 147.83 3.44 Favored 'General case' 0 N--CA 1.506 2.363 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' HD13 ' A' ' 51' ' ' LEU . 8.3 t -143.34 -155.98 0.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 17' ' ' VAL . 5.1 mp -81.93 80.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.6 m -163.22 -171.45 2.62 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.871 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.7 mt -131.8 31.31 4.24 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.014 0.821 . . . . 0.0 110.728 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' H ' HD13 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -128.02 29.74 5.36 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.691 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -132.3 85.88 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.368 0.604 . . . . 0.0 110.379 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.38 86.96 0.84 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.199 -1.0 . . . . 0.0 113.576 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' NH1' ' A' ' 44' ' ' ARG . 51.9 m -47.67 -58.67 4.0 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.362 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.427 ' CB ' HH12 ' A' ' 44' ' ' ARG . 5.0 m 175.07 -49.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.801 1.313 . . . . 0.0 110.461 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 tpp85 -157.72 35.35 0.26 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG11 ' SG ' ' A' ' 48' ' ' CYS . 2.3 p . . . . . 0 C--N 1.301 -1.516 0 CA-C-O 112.334 -3.698 . . . . 0.0 108.431 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 55.91 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 118.923 -0.56 . . . . 0.0 109.543 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 t -170.85 37.72 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 122.226 1.012 . . . . 0.0 110.936 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.08 -56.15 1.99 Allowed Glycine 0 N--CA 1.499 2.853 0 C-N-CA 119.193 -1.48 . . . . 0.0 109.896 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.488 ' CD2' HD11 ' A' ' 9' ' ' LEU . 49.2 t60 -86.94 -33.39 19.7 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.548 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.499 HG11 ' HA ' ' A' ' 47' ' ' ALA . 3.3 t -60.13 -35.46 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.823 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -53.34 -64.1 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.385 0.612 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.8 t -57.02 -21.32 30.05 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.322 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD11 ' CD2' ' A' ' 5' ' ' HIS . 64.4 mt -81.15 -31.14 34.25 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.3 m -100.1 -16.9 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.477 0.656 . . . . 0.0 111.885 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 4.3 tpt85 -59.49 -44.45 97.84 Favored Pre-proline 0 N--CA 1.494 1.749 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 72.7 Cg_endo -61.88 -25.9 78.62 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 121.408 1.405 . . . . 0.0 114.033 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' SG ' HG21 ' A' ' 31' ' ' VAL . 54.7 m -75.46 -18.77 59.77 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 118.602 -1.239 . . . . 0.0 111.035 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 54' ' ' ILE . 6.3 mp -64.21 -25.79 68.22 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.547 -0.721 . . . . 0.0 111.539 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.594 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 18.2 m -50.07 -27.53 5.76 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.181 0.991 . . . . 0.0 111.348 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -97.7 -44.0 6.94 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.642 ' CG2' HD11 ' A' ' 69' ' ' ILE . 8.6 t -57.56 -31.93 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.895 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 2.0 pt20 -61.23 -25.4 67.03 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.257 -0.902 . . . . 0.0 111.646 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.93 34.83 2.69 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.52 -165.64 10.46 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.66 141.95 42.8 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.051 1.168 . . . . 0.0 109.813 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.21 -156.89 27.99 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.942 -1.663 . . . . 0.0 108.942 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HD3' ' HE2' ' A' ' 72' ' ' LYS . 91.9 Cg_endo -68.15 -64.7 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.317 0 O-C-N 123.701 1.369 . . . . 0.0 113.038 -0.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.442 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 29.2 p 178.24 168.57 0.79 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.19 -3.56 82.01 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -106.32 -11.61 15.94 Favored 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 119.214 -0.994 . . . . 0.0 109.748 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 43.4 t -63.03 -45.31 92.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.8 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 46.1 m -81.11 -22.32 39.22 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -88.72 -47.96 7.86 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.15 -47.24 87.11 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.068 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.536 HG21 ' SG ' ' A' ' 13' ' ' CYS . 70.7 t -75.58 -39.75 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.987 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 69.5 tttt -59.0 -44.86 91.73 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -61.03 -57.22 13.52 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.827 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 tp -51.3 -56.25 14.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.931 -0.48 . . . . 0.0 110.184 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -49.7 -53.94 21.71 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.706 0.765 . . . . 0.0 110.848 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -54.13 -42.48 69.57 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.603 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -66.65 -40.45 88.67 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.935 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.05 78.69 0.93 Allowed 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.723 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -92.6 -14.5 28.12 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.407 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 82.5 p -104.47 158.67 16.32 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.683 0.754 . . . . 0.0 110.88 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -60.9 -37.77 83.39 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -54.18 38.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 122.07 -0.393 . . . . 0.0 111.484 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -63.96 -30.93 71.97 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 118.737 -1.185 . . . . 0.0 110.119 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 -75.08 -37.53 61.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.598 -0.689 . . . . 0.0 111.44 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -77.18 -35.91 55.49 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.383 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.5 m -65.01 -55.51 18.55 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.888 -1.125 . . . . 0.0 111.204 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -57.44 -35.21 69.81 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.291 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' ' CD1' ' A' ' 85' ' ' ILE . 3.9 t -57.63 -45.59 85.24 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.228 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -53.73 -44.65 70.08 Favored 'General case' 0 N--CA 1.503 2.224 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.019 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.492 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 97.1 m -50.69 -50.2 55.54 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 125.162 1.539 . . . . 0.0 111.727 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 51' ' ' LEU . 5.8 mp -66.96 -46.99 73.01 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 68.6 mttt -58.52 -54.38 47.74 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.21 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.11 -40.89 37.17 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.467 HG21 HD21 ' A' ' 14' ' ' LEU . 57.1 mt -69.17 -62.74 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.959 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.55 -42.93 11.5 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.314 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 -51.26 -29.19 13.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 124.237 0.961 . . . . 0.0 113.437 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.78 -19.17 27.72 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.0 mt -81.63 154.95 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -114.01 -47.79 2.94 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.276 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -93.65 80.09 4.27 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.01 155.58 16.72 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.905 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 35.2 t-20 -124.11 96.5 4.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.061 -0.4 . . . . 0.0 110.017 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -59.23 -35.73 74.18 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.068 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 8.4 t70 -56.54 -46.62 80.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.575 0.547 . . . . 0.0 110.112 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 92.2 m-20 -74.54 -46.62 37.89 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.047 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.54 -45.87 38.02 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 122.005 0.907 . . . . 0.0 110.255 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -25.57 58.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.996 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.3 m -80.79 -3.9 52.65 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.642 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.0 mt -68.96 -60.05 4.73 Favored Pre-proline 0 N--CA 1.503 2.204 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 36.5 Cg_endo -55.76 -46.07 34.4 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 N-CA-C 116.928 1.857 . . . . 0.0 116.928 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 60.6 Cg_endo -59.66 -55.76 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.707 1.604 . . . . 0.0 113.233 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.512 ' HE2' ' HD3' ' A' ' 23' ' ' PRO . 17.2 pttp -58.58 -34.6 71.25 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.321 -0.952 . . . . 0.0 112.044 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.76 -57.68 3.91 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.685 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 109.63 22.28 6.77 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.305 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.62 -29.79 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 118.883 -0.58 . . . . 0.0 110.373 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 t30 60.89 95.8 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 123.949 0.781 . . . . 0.0 112.667 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.426 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.1 mp -90.89 160.1 38.83 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.109 -0.994 . . . . 0.0 108.836 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.487 ' HB2' ' CG1' ' A' ' 90' ' ' VAL . 8.6 Cg_endo -88.0 6.95 4.75 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.456 1.24 . . . . 0.0 110.083 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.413 ' CB ' HG12 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -168.64 160.27 10.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 123.341 0.401 . . . . 0.0 111.175 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.0 t -141.41 -174.65 4.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.1 mp -75.82 73.06 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.483 ' C ' HD12 ' A' ' 83' ' ' LEU . 41.6 t -155.17 -168.91 3.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 82' ' ' SER . 6.5 mp -128.44 43.65 3.1 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.346 0.593 . . . . 0.0 109.842 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -97.08 -55.39 2.87 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.199 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 ' CD1' ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -77.91 151.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.46 28.78 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 117.307 -1.757 . . . . 0.0 111.668 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.479 ' SG ' ' HE3' ' A' ' 52' ' ' LYS . 38.1 m 47.15 11.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 p -119.51 30.69 6.95 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.893 -1.123 . . . . 0.0 112.049 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.88 40.45 0.56 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' A' ' 78' ' ' PRO . 35.8 m . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 114.187 -2.816 . . . . 0.0 112.622 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -105.52 138.46 41.67 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.8 t -61.29 -20.06 62.46 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.47 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -55.56 -32.98 58.63 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.931 -1.267 . . . . 0.0 109.931 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 0.7 OUTLIER -96.72 -39.54 9.42 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.858 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 47' ' ' ALA . 21.9 t -59.86 -35.48 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -50.64 -40.46 53.2 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.425 1.107 . . . . 0.0 110.554 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 94.7 p -77.93 -25.61 48.45 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.767 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 69.0 mt -77.18 -34.23 56.35 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 51' ' ' LEU . 10.8 m -84.84 -22.7 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 CA-C-O 122.394 1.092 . . . . 0.0 111.772 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.567 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -55.52 -47.63 98.21 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.8 Cg_endo -59.11 -33.37 98.41 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.737 1.625 . . . . 0.0 113.787 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.0 m -78.61 -33.13 47.67 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.655 1.217 . . . . 0.0 109.976 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.26 -31.31 70.09 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.249 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.403 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 29.5 m -53.77 -22.46 9.42 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.311 0.576 . . . . 0.0 112.089 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CD2' ' HB3' ' A' ' 65' ' ' ASN . 86.4 t80 -94.9 -43.93 7.96 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.218 1.009 . . . . 0.0 108.569 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.62 HG22 ' HA ' ' A' ' 66' ' ' ALA . 9.7 t -53.13 -31.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 114.06 -1.427 . . . . 0.0 112.26 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 15' ' ' SER . 1.6 pt20 -60.22 -31.23 69.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.363 -0.835 . . . . 0.0 111.37 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.98 41.35 1.0 Allowed Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -133.59 -173.38 13.21 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.46 143.49 47.65 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.59 1.526 . . . . 0.0 109.986 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.36 -159.65 28.72 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.639 -1.785 . . . . 0.0 108.639 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.7 -64.03 0.03 OUTLIER 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 123.744 -1.356 . . . . 0.0 112.985 3.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.8 p 174.39 166.8 0.24 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.045 0.84 . . . . 0.0 109.469 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.49 -4.96 81.66 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 107.057 -2.417 . . . . 0.0 107.057 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -102.84 -11.91 17.95 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.803 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 33.7 t -62.45 -48.3 80.23 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 95.1 m -74.08 -20.53 60.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -94.34 -37.69 11.36 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.293 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.94 -39.67 53.86 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.5 t -80.31 -44.26 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 22.2 ttpt -51.57 -46.17 63.34 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -59.02 -59.28 5.73 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.693 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 ' HB1' ' A' ' 47' ' ' ALA . 14.4 tp -49.17 -53.81 19.3 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.371 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -54.05 -53.46 52.74 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.143 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.377 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -79.77 69.09 6.03 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -147.16 93.41 2.25 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 120.954 0.406 . . . . 0.0 110.521 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.6 ttt85 -94.19 -13.51 26.58 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.835 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.2 m -134.46 153.59 51.84 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.323 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -49.89 -33.97 18.8 Favored 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.537 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -62.66 -34.19 76.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 112.683 0.624 . . . . 0.0 112.683 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -69.19 -33.42 73.33 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 117.491 -1.683 . . . . 0.0 111.664 -179.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HE ' ' HB3' ' A' ' 87' ' ' CYS . 21.9 ttp180 -78.96 -46.33 18.54 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.48 ' NE2' ' H ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -56.76 -38.06 71.93 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 m -60.23 -60.87 3.13 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 122.112 0.958 . . . . 0.0 110.235 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.9 -39.34 71.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.32 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.49 ' SG ' HG11 ' A' ' 90' ' ' VAL . 2.5 t -57.46 -37.01 72.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.813 1.321 . . . . 0.0 109.931 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -45.76 84.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 120.534 -0.467 . . . . 0.0 110.062 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.5 m -48.47 -59.59 3.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 124.503 1.127 . . . . 0.0 112.785 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.717 ' H ' HD12 ' A' ' 51' ' ' LEU . 5.4 mp -62.27 -39.48 93.05 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.196 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -67.32 -51.24 54.82 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.698 -1.201 . . . . 0.0 111.41 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.42 -40.87 87.13 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.8 mt -63.59 -66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-N 115.558 -0.321 . . . . 0.0 111.261 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -43.77 -42.48 5.54 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.457 0.646 . . . . 0.0 110.325 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.448 ' NE ' ' C ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -52.72 -28.61 22.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.13 -23.73 43.6 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -80.03 139.44 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -97.11 -50.63 4.52 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -87.26 71.82 9.96 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.642 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 81' ' ' ILE . 1.4 mt -85.65 133.99 34.01 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.218 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 61.5 t30 -103.91 118.58 37.03 Favored 'General case' 0 N--CA 1.506 2.352 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.157 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.73 -36.34 57.19 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -51.83 -46.37 64.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.121 0.888 . . . . 0.0 111.669 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 16' ' ' TYR . 68.3 m-20 -78.39 -46.22 20.48 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.62 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -46.63 -43.88 17.85 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 122.715 1.245 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.6 ttt-85 -77.91 -22.33 49.81 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.152 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 39.6 m -84.69 -2.52 57.66 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.262 -0.975 . . . . 0.0 112.684 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 17' ' ' VAL . 77.7 mt -78.71 -60.21 0.61 Allowed Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.9 Cg_endo -56.39 -42.63 63.79 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 N-CA-C 117.549 2.096 . . . . 0.0 117.549 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 61.1 Cg_endo -59.38 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.802 1.668 . . . . 0.0 113.963 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' A' ' 68' ' ' SER . 6.0 ptpp? -48.61 -30.84 5.81 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 14.9 t -67.47 -57.99 5.54 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 112.721 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.32 18.99 7.78 Favored Glycine 0 N--CA 1.501 2.98 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.963 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.61 -32.67 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.013 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 t30 57.88 88.82 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.854 0.721 . . . . 0.0 112.883 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mp -87.1 155.1 55.17 Favored Pre-proline 0 N--CA 1.5 2.062 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.266 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -84.73 -1.84 9.63 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.191 1.927 . . . . 0.0 110.119 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.658 ' CD2' ' SG ' ' A' ' 87' ' ' CYS . 40.3 p90 -166.02 137.77 3.82 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.414 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 7.1 t -134.94 -164.92 1.59 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.441 HG22 HD21 ' A' ' 61' ' ' LEU . 13.5 mm -75.38 71.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.3 t -164.37 151.48 11.58 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.95 54.46 0.85 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -133.31 31.98 3.73 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.592 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.559 HG12 ' HA ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -146.95 155.34 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.375 -0.828 . . . . 0.0 111.439 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -132.31 96.16 3.81 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.658 ' SG ' ' CD2' ' A' ' 79' ' ' TYR . 33.2 m -55.75 -60.87 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.126 -0.63 . . . . 0.0 111.155 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.1 m -178.63 -52.86 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.48 ' H ' ' NE2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -156.96 40.37 0.32 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG11 ' SG ' ' A' ' 48' ' ' CYS . 2.8 p . . . . . 0 C--N 1.303 -1.439 0 CA-C-O 111.785 -3.96 . . . . 0.0 108.311 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 2' ' ' ASP . 1.3 m-20 -97.69 45.94 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.311 1.053 . . . . 0.0 109.02 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.9 t 48.95 56.58 7.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 123.173 1.463 . . . . 0.0 111.458 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.51 -68.06 0.57 Allowed Glycine 0 N--CA 1.5 2.96 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.469 ' ND1' HD11 ' A' ' 9' ' ' LEU . 56.7 t-80 -70.95 -31.18 67.68 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.952 0.882 . . . . 0.0 109.724 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 47' ' ' ALA . 38.8 t -52.19 -35.31 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.21 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.51 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 1.8 m-20 -55.29 -62.62 1.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.704 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 t -57.26 -20.83 30.12 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 121.349 -0.845 . . . . 0.0 110.794 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.469 HD11 ' ND1' ' A' ' 5' ' ' HIS . 41.5 mt -81.96 -43.34 18.18 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.711 -0.618 . . . . 0.0 112.112 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.8 m -92.6 -22.64 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.611 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 34.1 mmm-85 -62.85 -41.28 70.63 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 58.3 Cg_endo -57.0 -30.79 87.93 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 C-N-CA 121.676 1.584 . . . . 0.0 114.014 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.655 ' SG ' HG21 ' A' ' 31' ' ' VAL . 63.6 m -77.05 -29.7 55.29 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.184 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 54' ' ' ILE . 66.2 mt -61.75 -28.9 69.77 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.643 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.5 t -53.21 -24.44 11.07 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.49 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -94.76 -44.49 7.76 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.599 ' CG2' HD11 ' A' ' 69' ' ' ILE . 39.5 t -52.66 -31.81 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.599 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -22.23 66.26 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.846 -0.534 . . . . 0.0 112.069 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.05 42.14 2.13 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.95 -172.56 12.57 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.35 131.32 21.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.63 1.554 . . . . 0.0 109.391 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -160.08 32.32 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . 83.2 Cg_endo -74.07 -60.26 0.09 OUTLIER 'Cis proline' 0 C--N 1.311 -1.425 0 C-N-CA 124.023 -1.24 . . . . 0.0 112.656 2.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.9 p 171.24 161.05 0.09 Allowed 'General case' 0 N--CA 1.501 2.118 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.253 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.39 -4.87 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.63 -15.86 16.23 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.909 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 69' ' ' ILE . 44.7 t -56.16 -48.65 75.91 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.141 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.3 t -72.78 -66.5 0.66 Allowed 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 118.64 -1.224 . . . . 0.0 110.785 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -48.86 -49.54 38.95 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.664 1.221 . . . . 0.0 110.057 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.85 -56.48 24.56 Favored Glycine 0 N--CA 1.487 2.09 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.755 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG21 ' SG ' ' A' ' 13' ' ' CYS . 31.3 t -71.04 -33.77 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.415 -1.05 . . . . 0.0 111.092 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.21 -47.78 77.72 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -59.69 -50.66 72.98 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.055 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 34' ' ' LEU . 5.4 tt -57.0 -55.12 38.78 Favored 'General case' 0 N--CA 1.505 2.295 0 CA-C-O 121.82 0.819 . . . . 0.0 109.101 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -49.89 -51.18 42.51 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.657 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -45.15 79.7 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.385 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -82.52 72.27 9.59 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.15 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.538 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -151.4 79.72 1.29 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.452 -0.794 . . . . 0.0 108.888 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.17 -4.36 23.22 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 14.0 m -116.99 150.81 37.98 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 118.985 -1.086 . . . . 0.0 111.322 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -54.9 -30.9 59.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.427 -0.795 . . . . 0.0 109.646 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.9 -37.76 72.97 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 91.0 m-20 -55.85 -48.35 75.67 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-O 122.367 1.079 . . . . 0.0 112.282 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.721 HH21 ' N ' ' A' ' 45' ' ' GLN . 15.4 ttp-105 -73.85 -46.1 47.02 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.257 -1.792 . . . . 0.0 110.677 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.721 ' N ' HH21 ' A' ' 44' ' ' ARG . 0.0 OUTLIER -62.91 -38.14 89.78 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 121.46 0.647 . . . . 0.0 111.006 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.613 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -53.87 -32.47 53.32 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.746 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.482 ' SG ' ' CE1' ' A' ' 79' ' ' TYR . 10.2 m -62.13 -38.64 89.71 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.851 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -63.36 -42.75 98.89 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.019 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.59 ' SG ' HG11 ' A' ' 6' ' ' VAL . 56.4 m -51.81 -59.27 4.5 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.675 1.226 . . . . 0.0 112.377 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 80' ' ' THR . 7.7 tp -52.56 -42.34 64.37 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.19 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' NZ ' ' OXT' ' A' ' 90' ' ' VAL . 71.0 tttt -63.1 -50.61 69.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.205 0.941 . . . . 0.0 110.564 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.94 -42.07 69.33 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 14' ' ' LEU . 1.7 mp -86.57 -58.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.924 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.75 -25.04 2.66 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.648 -0.657 . . . . 0.0 112.353 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -84.29 -25.02 29.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 124.038 0.836 . . . . 0.0 110.279 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.9 -27.66 49.28 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -71.57 133.81 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.212 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -92.17 -36.17 13.44 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -104.56 75.77 1.25 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 122.961 1.363 . . . . 0.0 110.835 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 tt -104.08 137.96 41.28 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.035 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -104.43 127.92 52.21 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.494 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -79.85 -31.57 40.47 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.854 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -55.0 -47.85 74.09 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.782 0.801 . . . . 0.0 109.154 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 82.6 m-20 -71.96 -46.59 56.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.727 -0.608 . . . . 0.0 109.868 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 81' ' ' ILE . . . -46.9 -40.03 13.34 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.779 1.276 . . . . 0.0 110.918 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.7 ttt-85 -82.36 -21.36 35.97 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.98 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 65' ' ' ASN . 7.8 t -81.65 -9.25 59.71 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.934 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.679 HG23 ' SG ' ' A' ' 27' ' ' CYS . 80.1 mt -71.3 -57.88 4.28 Favored Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.652 -0.655 . . . . 0.0 111.642 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 41.9 Cg_endo -58.46 -41.74 62.25 Favored 'Trans proline' 0 CA--C 1.55 1.277 0 N-CA-C 117.059 1.907 . . . . 0.0 117.059 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 72.2 Cg_endo -62.47 -50.66 4.16 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 C-N-CA 121.212 1.275 . . . . 0.0 111.545 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 68' ' ' SER . 2.1 ptpt -56.44 -27.38 56.61 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.474 -0.89 . . . . 0.0 112.365 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 50.7 t -86.37 -51.52 6.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.057 0.848 . . . . 0.0 110.448 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.99 22.72 8.15 Favored Glycine 0 N--CA 1.497 2.744 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.08 -21.24 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 1.2 t30 51.24 77.0 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.561 1.163 . . . . 0.0 114.059 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.4 156.87 74.9 Favored Pre-proline 0 N--CA 1.499 1.979 0 C-N-CA 118.887 -1.125 . . . . 0.0 110.599 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -86.0 -0.81 8.61 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.461 1.441 . . . . 0.0 110.234 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.482 ' CE1' ' SG ' ' A' ' 48' ' ' CYS . 23.5 p90 -166.44 106.92 0.67 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.917 -0.713 . . . . 0.0 112.228 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 80' ' ' THR . 52.7 m -148.06 16.74 1.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.585 -1.322 . . . . 0.0 111.815 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 4.7 mp -128.59 78.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 120.788 -1.195 . . . . 0.0 111.653 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.7 t 46.03 -148.66 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.818 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.5 ' H ' HD12 ' A' ' 83' ' ' LEU . 3.2 mp -89.96 31.82 0.95 Allowed 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.758 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -93.33 0.87 57.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 pp -121.88 152.77 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.403 -0.811 . . . . 0.0 109.785 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.57 100.79 8.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.1 m -60.86 -51.62 68.52 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.627 0.727 . . . . 0.0 112.579 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.6 t 173.72 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.514 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.699 ' N ' HE21 ' A' ' 45' ' ' GLN . 2.8 ttm180 -165.0 43.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.458 ' OXT' ' NZ ' ' A' ' 52' ' ' LYS . 7.1 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 60.5 mt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 122.254 1.026 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.37 148.74 44.37 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 48.6 t -75.84 68.19 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 123.068 1.414 . . . . 0.0 110.811 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.91 -32.32 2.89 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -104.54 -35.09 7.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.527 0.68 . . . . 0.0 110.347 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.64 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 23.7 t -64.65 -39.2 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.848 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -53.44 -49.24 67.8 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.031 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.2 t -68.79 -23.66 64.31 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.798 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 34' ' ' LEU . 19.8 mt -77.07 -36.87 55.53 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 6' ' ' VAL . 34.7 m -93.71 2.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.467 0.651 . . . . 0.0 111.443 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.618 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -73.37 -35.48 2.69 Favored Pre-proline 0 N--CA 1.499 2.008 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 83.4 Cg_endo -68.03 -27.84 35.76 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 121.168 1.246 . . . . 0.0 113.151 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.611 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.8 OUTLIER -83.3 -1.35 53.02 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.254 -1.778 . . . . 0.0 112.288 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.17 -32.99 65.19 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-O 121.668 0.747 . . . . 0.0 109.568 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 t -54.21 -29.7 47.18 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 122.114 0.959 . . . . 0.0 111.013 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -88.05 -46.76 9.05 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.428 0.632 . . . . 0.0 110.115 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.666 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.3 t -53.04 -34.91 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.63 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.57 -19.68 65.29 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.836 -1.165 . . . . 0.0 112.087 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.91 44.55 1.39 Allowed Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -135.7 -172.77 12.78 Favored Glycine 0 N--CA 1.5 2.937 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.08 144.08 51.26 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.445 1.43 . . . . 0.0 109.735 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.2 -156.66 26.84 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.86 -72.5 0.0 OUTLIER 'Cis proline' 0 C--N 1.314 -1.286 0 O-C-N 123.34 1.179 . . . . 0.0 112.704 -3.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 p -179.75 162.69 1.09 Allowed 'General case' 0 N--CA 1.502 2.14 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.571 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -85.9 6.97 79.46 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 107.269 -2.333 . . . . 0.0 107.269 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -107.83 -27.26 10.35 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' SG ' HG21 ' A' ' 31' ' ' VAL . 43.6 t -57.47 -49.18 77.09 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.605 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' LYS . 70.2 m -60.99 -22.12 64.19 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.511 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -90.33 -49.32 6.6 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.08 -39.02 94.53 Favored Glycine 0 N--CA 1.491 2.312 0 CA-C-N 116.356 -0.383 . . . . 0.0 113.388 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG21 ' SG ' ' A' ' 27' ' ' CYS . 22.8 t -82.84 -38.74 15.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 121.841 -0.799 . . . . 0.0 110.627 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 76.3 tttt -62.34 -42.49 99.43 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -57.6 -54.28 48.59 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.456 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.562 HD21 HG22 ' A' ' 6' ' ' VAL . 2.9 tm? -54.22 -57.13 12.34 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.016 0.913 . . . . 0.0 109.168 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.79 -50.03 56.99 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.521 0.677 . . . . 0.0 111.409 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -61.23 -36.58 80.33 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.424 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.64 -34.41 67.26 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.347 0.594 . . . . 0.0 109.57 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.07 78.74 0.5 Allowed 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 123.4 1.571 . . . . 0.0 112.778 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.45 -12.36 29.96 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.285 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.2 m -111.01 -177.37 3.19 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 124.008 0.817 . . . . 0.0 111.406 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -76.84 -41.28 44.71 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 m -50.34 -55.36 15.91 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.633 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -63.84 -21.52 66.48 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.524 -1.27 . . . . 0.0 111.894 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.2 mtt85 -85.73 -33.61 21.44 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -72.7 -48.18 41.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.2 m -59.67 -59.06 6.04 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 122.033 0.921 . . . . 0.0 112.196 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -54.23 -34.3 60.36 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.123 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -45.9 91.61 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -54.29 -37.65 65.01 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.32 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.64 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 60.3 m -54.78 -54.14 45.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 123.745 0.653 . . . . 0.0 109.861 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.35 -33.39 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.186 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.753 ' HD2' ' SG ' ' A' ' 87' ' ' CYS . 20.9 mtpt -67.73 -48.9 65.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.533 0.521 . . . . 0.0 111.659 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.99 -42.89 99.57 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.0 mt -55.37 -63.21 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.554 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -40.73 -39.53 1.12 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 122.738 1.256 . . . . 0.0 111.9 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -57.23 -32.39 66.49 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.069 -0.968 . . . . 0.0 112.41 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.58 30.56 9.42 Favored Glycine 0 N--CA 1.494 2.567 0 C-N-CA 120.321 -0.943 . . . . 0.0 111.643 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.5 mm -108.25 150.49 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -91.65 -46.66 7.81 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.526 -0.87 . . . . 0.0 108.811 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -132.4 75.57 1.64 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 tt -62.46 141.3 58.45 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.666 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.2 t-20 -114.82 120.77 41.15 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.61 -36.68 43.85 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -51.38 -44.6 62.2 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.504 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.1 m-20 -79.81 -48.68 13.15 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -48.35 -43.88 33.91 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.549 1.166 . . . . 0.0 111.054 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.71 -24.04 53.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.091 -1.413 . . . . 0.0 109.965 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.5 m -86.07 0.53 53.22 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.651 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.611 HD13 ' HB3' ' A' ' 13' ' ' CYS . 65.0 mt -79.9 -61.72 0.44 Allowed Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 38.6 Cg_endo -55.93 -42.71 64.06 Favored 'Trans proline' 0 CA--C 1.549 1.248 0 N-CA-C 116.909 1.85 . . . . 0.0 116.909 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 59.0 Cg_endo -59.81 -56.62 1.11 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.807 1.671 . . . . 0.0 112.911 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -60.39 -40.78 92.11 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.434 -0.907 . . . . 0.0 111.199 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 13.3 t -61.94 -51.95 66.03 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.223 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.0 39.38 4.08 Favored Glycine 0 N--CA 1.5 2.915 0 N-CA-C 105.558 -3.017 . . . . 0.0 105.558 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 73' ' ' CYS . 54.2 t -117.06 -40.95 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.132 -1.034 . . . . 0.0 109.114 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.6 t30 60.01 72.44 0.53 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 124.209 0.943 . . . . 0.0 112.156 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.75 154.88 87.22 Favored Pre-proline 0 N--CA 1.506 2.347 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.4 1.04 8.9 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.514 1.27 . . . . 0.0 110.017 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CD1' ' C ' ' A' ' 79' ' ' TYR . 12.3 p90 -169.82 166.02 9.67 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.624 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.5 t -152.79 -164.05 1.85 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.54 90.77 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 83' ' ' LEU . 18.2 t -175.52 -168.01 0.28 Allowed 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.232 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.484 ' N ' ' OG ' ' A' ' 82' ' ' SER . 4.1 mp -137.39 45.69 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 123.789 0.681 . . . . 0.0 110.323 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -104.52 5.56 34.07 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 121.228 0.537 . . . . 0.0 111.037 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG13 ' HB3' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.85 148.76 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.539 -0.725 . . . . 0.0 111.477 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -86.18 -15.32 41.34 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.675 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.753 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 45.0 m 52.15 17.97 0.79 Allowed 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 p -104.33 -43.92 5.08 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.979 0.895 . . . . 0.0 110.179 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.61 32.0 5.37 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 113.955 -1.475 . . . . 0.0 113.995 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.499 2.019 0 O-C-N 125.646 1.841 . . . . 0.0 109.824 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 11.7 tt . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.51 145.13 29.09 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 t -76.69 67.79 2.84 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.287 -1.365 . . . . 0.0 110.242 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.62 -56.35 0.91 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -86.95 -30.94 20.93 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 47' ' ' ALA . 13.8 t -59.07 -37.49 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.738 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -52.52 -47.73 66.47 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.768 0.794 . . . . 0.0 111.332 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.0 t -81.11 -11.13 59.55 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.585 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.54 -34.14 21.59 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 118.795 0.725 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 51' ' ' LEU . 20.8 m -88.08 -23.79 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-O 122.132 0.968 . . . . 0.0 110.915 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -55.67 -47.57 98.41 Favored Pre-proline 0 N--CA 1.5 2.075 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 55.8 Cg_endo -56.38 -34.29 93.94 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 121.944 1.763 . . . . 0.0 114.024 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 31' ' ' VAL . 73.4 m -80.55 -28.83 37.17 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 119.281 0.946 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' CD1' ' CG2' ' A' ' 54' ' ' ILE . 9.1 tt -65.26 -32.11 73.61 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.788 0.804 . . . . 0.0 110.553 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.2 p -54.69 -23.56 18.05 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.873 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -94.26 -45.98 7.27 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.675 0.75 . . . . 0.0 109.738 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG22 ' HA ' ' A' ' 66' ' ' ALA . 39.4 t -51.25 -33.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-N 114.38 -1.282 . . . . 0.0 112.155 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -61.32 -26.91 68.11 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 119.864 -0.735 . . . . 0.0 111.836 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.62 36.85 1.83 Allowed Glycine 0 N--CA 1.499 2.841 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.15 -172.07 13.03 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.52 135.38 28.52 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.609 1.539 . . . . 0.0 109.287 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.69 -160.4 31.43 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.73 -63.24 0.03 OUTLIER 'Cis proline' 0 C--N 1.311 -1.396 0 C-N-CA 123.765 -1.348 . . . . 0.0 113.105 1.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 p 169.16 161.16 0.05 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.99 -9.16 59.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -96.74 -16.58 20.8 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.067 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -57.72 -42.88 84.71 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.023 -1.071 . . . . 0.0 109.043 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 32.1 m -76.28 -58.82 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.551 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -57.72 -47.09 83.39 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.884 0.849 . . . . 0.0 108.88 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.85 -52.24 54.42 Favored Glycine 0 N--CA 1.491 2.311 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.365 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.606 HG21 ' SG ' ' A' ' 13' ' ' CYS . 73.2 t -75.81 -39.59 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.718 -0.872 . . . . 0.0 110.619 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -51.39 -46.19 62.76 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -62.67 -53.12 59.29 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.48 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.2 tp -51.11 -54.33 26.06 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.677 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -49.9 -56.43 10.55 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.051 0.929 . . . . 0.0 109.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -56.82 -30.23 63.53 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.179 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -70.03 -19.98 63.28 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.822 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.95 82.05 2.19 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.72 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -93.25 -27.99 16.51 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.1 t -113.62 154.32 27.4 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.657 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.47 -42.68 23.22 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.471 1.129 . . . . 0.0 108.96 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -35.82 79.76 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 113.978 -1.465 . . . . 0.0 113.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.29 -41.29 98.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.424 ' HE ' ' HB3' ' A' ' 87' ' ' CYS . 20.4 ttp180 -72.78 -52.11 16.33 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -42.26 45.38 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.327 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 m -58.15 -63.87 1.11 Allowed 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 122.38 1.086 . . . . 0.0 111.447 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.93 -34.05 65.26 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.676 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.533 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . 10.9 m -60.21 -41.34 92.79 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.448 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -37.31 85.89 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 117.879 -1.529 . . . . 0.0 111.382 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -49.19 -61.86 1.85 Allowed 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 123.025 1.393 . . . . 0.0 108.694 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD12 ' CE2' ' A' ' 79' ' ' TYR . 14.7 mt -58.07 -50.87 71.97 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 114.736 -1.12 . . . . 0.0 112.396 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -53.82 -56.04 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 124.301 1.001 . . . . 0.0 110.238 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.93 -36.07 71.61 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 53.0 mt -72.37 -64.48 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.222 0.534 . . . . 0.0 111.158 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.89 -39.28 5.27 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.145 0.974 . . . . 0.0 110.503 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -30.52 49.55 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.171 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.06 -17.03 68.17 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.4 mt -76.42 -46.92 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.43 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 68.55 -57.72 0.49 Allowed 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 122.944 0.498 . . . . 0.0 111.518 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -97.05 48.5 1.05 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -68.8 178.87 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.846 -0.534 . . . . 0.0 110.374 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 28.1 t-20 -118.38 106.84 13.15 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.833 -0.747 . . . . 0.0 111.748 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -62.66 -39.36 93.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.069 0.855 . . . . 0.0 110.082 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -56.67 -46.99 80.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.636 1.21 . . . . 0.0 110.024 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -71.21 -51.02 27.02 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.588 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.539 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -48.63 -47.68 40.04 Favored 'General case' 0 N--CA 1.505 2.291 0 CA-C-O 122.532 1.158 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.4 ' O ' ' CD ' ' A' ' 71' ' ' PRO . 15.2 ttm180 -70.29 -24.85 63.11 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.191 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.8 m -82.48 -5.16 58.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' CYS . 88.0 mt -76.96 -56.11 1.34 Allowed Pre-proline 0 N--CA 1.503 2.205 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HG2' ' HD3' ' A' ' 71' ' ' PRO . 40.8 Cg_endo -60.81 -42.81 35.4 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 N-CA-C 116.773 1.797 . . . . 0.0 116.773 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD3' ' HG2' ' A' ' 70' ' ' PRO . 64.1 Cg_endo -62.91 -56.27 0.63 Allowed 'Trans proline' 0 N--CA 1.487 1.141 0 C-N-CA 121.255 1.303 . . . . 0.0 112.387 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -55.18 -30.78 60.58 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -77.59 -57.51 3.77 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.691 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 111.09 20.54 7.08 Favored Glycine 0 N--CA 1.5 2.95 0 C-N-CA 120.29 -0.957 . . . . 0.0 112.401 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.18 -28.39 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-O 118.98 -0.533 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.9 t30 58.28 94.56 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.358 1.036 . . . . 0.0 113.439 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.67 151.13 38.92 Favored Pre-proline 0 N--CA 1.504 2.26 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.381 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -87.51 5.54 5.53 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.856 1.451 . . . . 0.0 110.799 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.554 ' CE2' HD12 ' A' ' 51' ' ' LEU . 20.4 p90 -165.33 147.04 7.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.491 ' HA ' HD13 ' A' ' 51' ' ' LEU . 4.3 t -156.19 -158.5 0.8 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 81' ' ' ILE . 3.5 mp -80.75 68.78 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.5 t -150.36 -173.16 4.37 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.28 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.3 mt -139.3 44.3 2.0 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.003 0.814 . . . . 0.0 111.23 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -136.71 30.81 2.82 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.995 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -147.22 176.85 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.107 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.21 119.3 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.735 1.272 . . . . 0.0 107.986 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.424 ' HB3' ' HE ' ' A' ' 44' ' ' ARG . 92.0 m -67.15 -42.28 84.64 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.259 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 44' ' ' ARG . 8.5 t 165.54 -51.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 123.865 0.728 . . . . 0.0 109.59 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -161.28 41.78 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.305 -1.366 0 CA-C-O 114.131 -2.842 . . . . 0.0 107.431 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.2 mt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.24 -79.53 0.58 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 7' ' ' ASP . 8.0 t -171.92 40.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.894 0.854 . . . . 0.0 110.439 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.42 -41.18 6.6 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -104.79 -31.22 9.42 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.588 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 47' ' ' ALA . 64.6 t -65.41 -38.67 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.695 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' HB2' ' SG ' ' A' ' 3' ' ' CYS . 31.0 t70 -50.36 -44.26 54.52 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 122.479 1.133 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.7 t -78.58 -23.56 45.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.109 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 6' ' ' VAL . 52.3 mt -75.74 -39.8 56.6 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.942 -0.474 . . . . 0.0 111.137 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' O ' HD13 ' A' ' 14' ' ' LEU . 30.7 m -85.05 -20.91 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.317 0 CA-C-O 121.379 0.609 . . . . 0.0 111.357 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.587 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -54.86 -47.48 98.16 Favored Pre-proline 0 N--CA 1.501 2.11 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 52.6 Cg_endo -56.75 -33.54 94.31 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.742 1.628 . . . . 0.0 114.798 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' HG21 ' A' ' 31' ' ' VAL . 98.5 m -79.61 -24.81 41.73 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.97 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 10' ' ' VAL . 9.8 mp -65.91 -33.54 76.08 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.566 -0.709 . . . . 0.0 110.396 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.3 m -52.69 -23.29 6.37 Favored 'General case' 0 N--CA 1.505 2.314 0 CA-C-O 121.423 0.63 . . . . 0.0 112.545 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -93.98 -46.02 7.34 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.974 0.892 . . . . 0.0 108.952 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 66' ' ' ALA . 8.0 t -54.57 -29.44 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.17 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -66.79 -18.11 65.21 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.51 -0.744 . . . . 0.0 111.815 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.87 43.75 2.58 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -137.5 -172.46 12.54 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.98 132.88 23.9 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.7 1.6 . . . . 0.0 109.487 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.56 -161.3 33.56 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HG2' ' H ' ' A' ' 24' ' ' SER . 86.2 Cg_endo -72.33 -64.53 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.899 -1.292 . . . . 0.0 112.135 3.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 52.8 p 171.06 161.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 124.072 0.857 . . . . 0.0 109.21 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.05 -5.88 54.66 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.88 -24.44 16.43 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' SG ' HG23 ' A' ' 69' ' ' ILE . 39.3 t -54.52 -40.14 68.3 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.568 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 m -82.48 -63.78 1.31 Allowed 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 118.194 -1.402 . . . . 0.0 110.973 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -55.25 -44.98 76.06 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 119.547 1.067 . . . . 0.0 108.779 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.19 -57.95 17.04 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-O 122.064 0.813 . . . . 0.0 112.741 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG21 ' SG ' ' A' ' 13' ' ' CYS . 47.7 t -70.11 -35.27 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.115 -1.226 . . . . 0.0 111.859 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -55.58 -45.9 77.29 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 29' ' ' ASP . 85.0 m-20 -65.04 -45.95 83.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.938 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.529 HD11 HG13 ' A' ' 6' ' ' VAL . 5.6 tt -59.48 -54.28 48.45 Favored 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 122.777 1.275 . . . . 0.0 108.95 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -48.73 -55.62 10.9 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.557 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.29 -38.93 69.27 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.298 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -65.41 -38.56 90.32 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 124.207 0.942 . . . . 0.0 111.412 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.16 92.73 0.27 Allowed 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 122.099 0.952 . . . . 0.0 113.275 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -18.74 20.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.748 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -130.05 163.98 25.35 Favored 'General case' 0 N--CA 1.504 2.229 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.5 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' OE1' ' NH2' ' A' ' 89' ' ' ARG . 7.6 mt-30 -53.55 -35.18 60.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -39.23 59.25 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.772 -0.58 . . . . 0.0 110.789 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -85.58 -20.84 28.95 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.794 -1.563 . . . . 0.0 111.306 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mtp85 -79.95 -41.01 26.86 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -73.88 -37.75 64.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.4 m -63.62 -59.37 4.69 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.568 -1.253 . . . . 0.0 110.711 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -55.14 -26.87 41.38 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.902 -1.119 . . . . 0.0 111.898 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 47.9 t -65.13 -49.39 70.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -52.35 -37.75 56.9 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.5 m -57.0 -65.42 0.62 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 122.155 0.979 . . . . 0.0 110.214 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' O ' HD12 ' A' ' 81' ' ' ILE . 2.3 pp -66.65 -36.99 83.88 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.243 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.498 ' N ' HD12 ' A' ' 51' ' ' LEU . 87.3 tttt -70.41 -45.12 66.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 109.915 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -39.0 80.97 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.83 -62.76 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.842 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.52 -38.42 6.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.21 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -26.49 35.41 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.919 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.98 -21.58 17.88 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mt -73.03 -39.46 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.692 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.432 ' HD1' ' C ' ' A' ' 59' ' ' HIS . 2.1 t-80 69.14 -57.08 0.53 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 123.041 0.536 . . . . 0.0 111.776 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -96.21 83.66 3.64 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG13 ' A' ' 81' ' ' ILE . 7.9 tt -102.72 151.51 22.3 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.683 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 64.3 t30 -98.4 96.02 7.74 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.052 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.45 -38.97 75.29 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.293 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.39 -49.54 34.34 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 124.528 1.143 . . . . 0.0 111.887 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -76.85 -44.25 32.99 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.908 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 17' ' ' VAL . . . -50.14 -41.03 48.12 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.426 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -81.56 -16.18 52.45 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.3 m -87.11 -0.99 57.55 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.039 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 13' ' ' CYS . 60.0 mt -78.75 -61.09 0.54 Allowed Pre-proline 0 N--CA 1.503 2.221 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 37.8 Cg_endo -56.28 -42.21 68.39 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 N-CA-C 116.826 1.818 . . . . 0.0 116.826 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 72.0 Cg_endo -62.13 -59.4 0.27 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.809 1.673 . . . . 0.0 112.824 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 71' ' ' PRO . 20.4 ptmt -54.8 -41.54 70.72 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 123.749 0.655 . . . . 0.0 110.827 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.49 -51.33 69.9 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.31 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.44 38.86 4.11 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 105.614 -2.995 . . . . 0.0 105.614 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.2 t -121.57 -37.53 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-N 114.056 -1.072 . . . . 0.0 111.177 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 2.6 t30 52.24 74.67 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.2 mp -70.45 159.22 85.61 Favored Pre-proline 0 N--CA 1.499 1.989 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.108 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.48 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 30.3 Cg_endo -85.56 -1.99 9.09 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.259 1.306 . . . . 0.0 109.277 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' HA ' HG12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -162.5 159.57 25.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 123.404 0.44 . . . . 0.0 111.413 -179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 t -147.6 -175.46 4.87 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.559 ' CG2' HG21 ' A' ' 17' ' ' VAL 0.274 0.9 OUTLIER -75.23 69.27 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 -179.744 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.2 t -152.57 164.6 37.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.1 mt -106.12 54.91 0.68 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -121.8 -55.17 1.91 Allowed 'General case' 0 N--CA 1.502 2.155 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.992 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -60.2 161.3 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.672 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -121.9 89.21 3.08 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.489 0.662 . . . . 0.0 111.748 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.4 m -61.73 -8.04 4.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.28 -0.888 . . . . 0.0 112.944 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -83.21 -7.7 59.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 109.341 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -138.44 44.7 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 N--CA 1.504 2.231 0 CA-C-O 117.02 -1.467 . . . . 0.0 110.735 179.822 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 58.4 -87.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -170.09 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.888 1.328 . . . . 0.0 111.309 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -30.77 10.08 Favored Glycine 0 N--CA 1.504 3.192 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.136 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -112.4 -32.25 6.56 Favored 'General case' 0 N--CA 1.507 2.401 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.942 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.624 HG11 ' HA ' ' A' ' 47' ' ' ALA . 72.1 t -64.22 -32.09 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.912 -0.493 . . . . 0.0 110.939 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' OD2' ' NH1' ' A' ' 11' ' ' ARG . 37.8 t70 -51.49 -46.71 63.27 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.421 1.582 . . . . 0.0 111.097 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.3 p -77.79 -26.52 49.73 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.14 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 mt -74.77 -37.36 62.47 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 m -86.61 -15.91 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 CA-C-O 121.438 0.637 . . . . 0.0 111.026 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.607 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -57.66 -46.87 99.72 Favored Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 49.6 Cg_endo -55.92 -36.6 95.94 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.127 1.885 . . . . 0.0 114.461 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 31' ' ' VAL . 95.8 m -77.21 -18.23 57.88 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 119.341 -0.944 . . . . 0.0 111.662 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 54' ' ' ILE . 5.9 mp -70.57 -30.82 67.62 Favored 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 119.944 -0.703 . . . . 0.0 111.28 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.8 t -54.43 -23.1 14.51 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-O 121.611 0.72 . . . . 0.0 111.214 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -97.27 -45.01 6.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.973 0.892 . . . . 0.0 109.062 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.8 t -54.39 -30.78 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.713 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -64.97 -23.29 67.18 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 121.215 -0.928 . . . . 0.0 111.75 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.1 39.92 2.2 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.62 -166.49 10.66 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.17 136.77 30.02 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.676 1.584 . . . . 0.0 109.794 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.99 -160.48 31.21 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.396 -1.882 . . . . 0.0 108.396 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.425 ' HG2' ' H ' ' A' ' 24' ' ' SER . 84.9 Cg_endo -73.21 -63.1 0.03 OUTLIER 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 124.045 -1.231 . . . . 0.0 112.497 3.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.425 ' H ' ' HG2' ' A' ' 23' ' ' PRO . 51.6 p 170.05 160.39 0.07 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.584 1.177 . . . . 0.0 109.101 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.56 -6.03 53.04 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -97.71 -18.89 18.58 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 69' ' ' ILE . 43.2 t -58.58 -40.02 81.99 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.134 -1.026 . . . . 0.0 109.167 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 14.2 m -80.33 -62.61 1.62 Allowed 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.557 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -52.44 -49.89 63.7 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 122.468 1.128 . . . . 0.0 109.645 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.11 26.8 Favored Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.874 -1.512 . . . . 0.0 113.663 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.631 HG21 ' SG ' ' A' ' 13' ' ' CYS . 49.0 t -72.74 -36.65 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.78 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -56.06 -46.45 78.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -61.31 -55.08 35.79 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.849 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' C ' HD23 ' A' ' 34' ' ' LEU . 4.5 tt -52.72 -56.22 17.14 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -49.5 -56.66 9.03 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.538 0.685 . . . . 0.0 110.196 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.44 -39.74 76.9 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.55 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -65.4 -36.64 84.56 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.069 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.86 99.66 1.08 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.994 0.902 . . . . 0.0 112.26 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ttt85 -108.7 -23.93 11.56 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.11 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 p -118.8 176.77 5.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.543 1.163 . . . . 0.0 113.14 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -64.92 -30.91 71.93 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.6 p -57.48 -35.08 69.72 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.3 -0.875 . . . . 0.0 111.657 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -90.65 -33.4 15.84 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.563 1.173 . . . . 0.0 108.986 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -74.76 -36.45 62.57 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.07 -1.019 . . . . 0.0 112.907 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -79.78 -40.99 27.47 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.6 m -60.8 -57.72 11.48 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 118.619 -1.232 . . . . 0.0 110.693 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.624 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -56.55 -35.23 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.306 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.0 t -60.66 -39.68 89.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 118.755 -1.178 . . . . 0.0 107.969 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -62.47 -36.84 83.75 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.919 -1.113 . . . . 0.0 111.497 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 93.1 m -54.82 -58.59 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.76 1.267 . . . . 0.0 109.704 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.23 -42.69 86.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.346 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.32 -55.54 20.61 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.31 -38.36 90.07 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.469 HG21 HD21 ' A' ' 14' ' ' LEU . 38.4 mt -67.76 -63.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.353 0.678 . . . . 0.0 111.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.71 -36.99 3.42 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.056 0.931 . . . . 0.0 111.904 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -67.42 -23.56 65.56 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.482 -1.236 . . . . 0.0 113.395 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -101.61 23.37 35.24 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.8 mt -121.75 136.62 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -90.2 -31.57 16.98 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.743 -0.783 . . . . 0.0 108.997 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -106.54 78.07 1.24 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 tp -89.53 130.53 35.84 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 21.0 t-20 -114.35 93.9 4.56 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.612 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.79 -35.48 78.31 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.156 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.62 -49.31 68.11 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 91.8 m-20 -68.07 -51.36 47.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.849 -0.532 . . . . 0.0 110.323 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' HB1' ' OG1' ' A' ' 80' ' ' THR . . . -45.1 -45.28 11.06 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.773 0.797 . . . . 0.0 111.374 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -22.94 47.83 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.503 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.0 m -84.11 1.13 45.61 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.574 HD13 ' HB3' ' A' ' 13' ' ' CYS . 69.5 mt -77.5 -60.91 0.69 Allowed Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 37.0 Cg_endo -55.43 -43.18 60.76 Favored 'Trans proline' 0 CA--C 1.548 1.184 0 N-CA-C 117.425 2.048 . . . . 0.0 117.425 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 56.2 Cg_endo -58.98 -59.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.401 . . . . 0.0 113.094 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 7.1 ptpt -55.33 -36.85 66.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.994 0.809 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 10.6 t -69.65 -57.29 5.34 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.591 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.54 20.71 7.99 Favored Glycine 0 N--CA 1.496 2.686 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.666 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -112.61 -25.46 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.169 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 9.1 t30 54.8 91.54 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 124.368 1.042 . . . . 0.0 113.42 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HG ' ' HD2' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -83.39 158.67 63.17 Favored Pre-proline 0 N--CA 1.501 2.101 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.781 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.438 ' HD2' ' HG ' ' A' ' 77' ' ' LEU . 34.6 Cg_endo -89.08 7.03 4.36 Favored 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.948 1.499 . . . . 0.0 108.813 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -170.28 159.17 7.09 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.514 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.45 ' OG1' ' HB1' ' A' ' 66' ' ' ALA . 9.8 t -143.44 -153.69 0.48 Allowed 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.8 mp -85.81 78.32 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -154.8 172.8 17.39 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 122.296 -0.253 . . . . 0.0 110.718 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.91 44.72 2.12 Favored 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 120.574 -0.451 . . . . 0.0 109.84 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -115.2 -27.32 7.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.294 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.26 160.53 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.75 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 87' ' ' CYS . 8.9 t70 -92.18 -36.91 13.02 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 86' ' ' ASP . 64.2 m 75.77 -56.02 0.6 Allowed 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.636 0.731 . . . . 0.0 110.324 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.9 t -75.68 -29.44 59.05 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.958 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HE ' ' C ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -119.73 61.08 0.84 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.604 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' C ' HH21 ' A' ' 89' ' ' ARG . 30.2 m . . . . . 0 N--CA 1.5 2.043 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -62.03 141.03 58.31 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.809 -0.756 . . . . 0.0 109.753 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 6' ' ' VAL . 20.3 t -80.47 67.74 6.42 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.452 -1.699 . . . . 0.0 110.442 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.68 -49.37 1.29 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -89.8 -32.15 17.06 Favored 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.243 0.544 . . . . 0.0 109.615 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG11 ' HA ' ' A' ' 47' ' ' ALA . 98.0 t -54.73 -37.0 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.292 0.567 . . . . 0.0 111.084 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.2 -59.69 3.92 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 122.185 0.993 . . . . 0.0 111.475 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -59.1 -26.07 64.36 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.36 -37.24 60.73 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 121.559 -0.713 . . . . 0.0 111.045 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.71 -5.3 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 121.222 0.534 . . . . 0.0 112.406 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.609 ' N ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -68.56 -37.72 10.83 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 11' ' ' ARG . 89.2 Cg_endo -65.22 -29.58 55.34 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 C-N-CA 121.141 1.228 . . . . 0.0 113.798 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' HD13 ' A' ' 69' ' ' ILE . 0.6 OUTLIER -85.94 -9.46 56.85 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 117.18 -1.808 . . . . 0.0 112.29 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.31 -33.39 75.17 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 122.042 0.925 . . . . 0.0 109.539 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.2 m -56.91 -23.5 45.49 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.711 0.767 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -90.78 -45.57 8.75 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.747 0.784 . . . . 0.0 108.987 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 62' ' ' ASN . 17.5 t -53.11 -34.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 114.308 -1.315 . . . . 0.0 111.624 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.25 -20.07 66.01 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.941 -1.1 . . . . 0.0 111.463 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.68 43.79 1.51 Allowed Glycine 0 N--CA 1.5 2.908 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.89 -173.98 13.28 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.32 143.71 48.91 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.342 1.361 . . . . 0.0 109.988 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.62 -152.8 24.43 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -58.98 -71.49 0.0 OUTLIER 'Cis proline' 0 C--N 1.312 -1.386 0 O-C-N 123.164 1.086 . . . . 0.0 113.728 -8.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.4 p 179.92 163.74 1.08 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.513 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.02 6.33 83.64 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 106.341 -2.703 . . . . 0.0 106.341 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -105.96 -27.09 11.39 Favored 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.41 ' SG ' HG21 ' A' ' 31' ' ' VAL . 42.1 t -54.86 -57.18 12.64 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.331 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 69.4 m -56.0 -16.54 5.03 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -92.29 -50.63 5.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.41 -37.16 79.11 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 121.235 -0.507 . . . . 0.0 111.858 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG21 ' SG ' ' A' ' 27' ' ' CYS . 53.1 t -77.71 -46.08 27.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 121.737 -0.86 . . . . 0.0 110.062 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.9 -45.53 82.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -53.41 -58.65 6.37 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.568 ' CD1' HG13 ' A' ' 6' ' ' VAL . 8.4 tt -52.39 -56.83 12.33 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 122.401 1.096 . . . . 0.0 109.695 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -47.89 -52.83 17.78 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.63 1.205 . . . . 0.0 110.129 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -61.77 -40.75 96.27 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.644 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.85 -39.6 94.88 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.043 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 43' ' ' ASP . . . -67.8 93.34 0.39 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -110.9 9.95 22.37 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.894 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.4 p -122.13 -172.27 2.42 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 41' ' ' GLN . 53.6 tt0 -97.15 14.47 25.72 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.43 -44.25 2.99 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.801 -0.562 . . . . 0.0 109.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -57.23 -34.01 68.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.979 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.49 -26.37 28.2 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.142 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.13 -35.36 42.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 m -65.96 -58.12 6.26 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.594 ' HA ' HG11 ' A' ' 6' ' ' VAL . . . -59.59 -30.6 68.78 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.194 -1.403 . . . . 0.0 112.048 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.526 ' SG ' HD13 ' A' ' 85' ' ' ILE . 46.6 t -60.87 -45.95 92.52 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -54.92 -40.83 70.27 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.002 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 47' ' ' ALA . 33.0 m -49.98 -58.29 5.78 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 122.312 1.053 . . . . 0.0 109.549 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -60.57 -38.59 85.08 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.214 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -61.43 -59.9 4.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.222 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.23 -37.78 60.12 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.6 mt -66.14 -64.0 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 124.367 0.686 . . . . 0.0 109.731 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.38 -40.19 1.66 Allowed 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.887 1.327 . . . . 0.0 111.022 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -54.68 -31.38 57.76 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.932 -1.031 . . . . 0.0 113.144 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.52 29.74 11.87 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.779 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.3 mm -107.33 129.35 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -82.63 -50.08 9.13 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.542 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -114.8 71.06 0.75 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 122.015 0.912 . . . . 0.0 109.07 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -75.23 144.93 42.37 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.644 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.651 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 26.3 t-20 -121.9 112.01 17.79 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.2 -34.92 71.31 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.919 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 30.3 t70 -52.61 -46.55 67.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.477 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 17' ' ' VAL . 87.4 m-20 -74.34 -47.76 32.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.225 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -50.96 -42.71 60.14 Favored 'General case' 0 N--CA 1.511 2.605 0 CA-C-O 121.84 0.828 . . . . 0.0 110.767 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.2 ttt-85 -80.62 -16.03 55.1 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.678 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -87.66 -5.81 58.54 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.526 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 13' ' ' CYS . 46.9 mt -76.96 -61.08 0.73 Allowed Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.24 -0.912 . . . . 0.0 109.122 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' N ' ' HD2' ' A' ' 71' ' ' PRO . 42.9 Cg_endo -58.46 -41.79 61.67 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 N-CA-C 116.498 1.692 . . . . 0.0 116.498 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 70' ' ' PRO . 90.5 Cg_endo -63.48 -17.02 58.14 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 C-N-CA 121.595 1.53 . . . . 0.0 112.646 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 73' ' ' CYS . 25.2 pttt -106.45 -35.64 7.04 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.928 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 16.3 t -57.84 -50.42 73.35 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 10.56 14.21 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 119.884 -1.15 . . . . 0.0 113.489 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.63 -24.62 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.11 74.22 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.61 152.94 73.01 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 13.3 Cg_endo -89.34 8.14 3.9 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.395 1.208 . . . . 0.0 109.922 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.43 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 2.0 p90 -169.2 162.06 10.49 Favored 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.433 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.1 t -155.46 -171.49 3.81 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.96 91.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.3 t -163.2 -176.37 4.78 Favored 'General case' 0 N--CA 1.506 2.352 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.417 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.97 29.36 6.49 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.417 1.073 . . . . 0.0 109.029 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -91.11 -61.67 1.61 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.553 0.533 . . . . 0.0 111.447 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.526 HD13 ' SG ' ' A' ' 48' ' ' CYS . 2.8 pp -76.7 158.31 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.1 27.95 8.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.591 0.557 . . . . 0.0 110.571 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.3 m 52.52 14.84 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.8 p -110.9 -52.24 2.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.032 0.833 . . . . 0.0 111.6 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -103.4 52.14 0.78 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.524 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 117.564 -1.207 . . . . 0.0 109.36 179.901 . . . . . . . . 0 0 . 1 stop_ save_